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CORTICAL BONE TISSUE ENGINEERING:
SCAFFOLD DESIGN AND CELL SELECTION
DEMIN WEN
ABSTRACT
Cortical bone tissue engineering provides a promising approach to generate graft
materials needed to treat the large sized bone defects. The underling premise of tissue
engineering is to mimic the in vivo microenvironment as best as possible in vitro culture
system. To select an appropriate scaffold material used in this model system, mechanical
and

hydraulic

permeability

properties

of

316L

porous

stainless

steel

and

polymethylmethacrylate (PMMA) were studied, as well as their biocompatibility in short
and long term cell culture. Results showed that scaffolds made of both stainless steel and
PMMA: (1) could be manufactured to have similar permeability as that cortical bone, (2)
exhibited biocompatibility in short term cell culture; and that as the ultimate tensile
strength was concerned, the scaffold made of stainless steel was similar to cortical bone
while not PMMA; and that as the elastic modulus was concerned, neither scaffolds made
of stainless steel or PMMA was similar to cortical bone. To establish an optimal culture
condition and select an appropriate cell source, the influence of an artificial osteoid layer
made from type I collagen and fibronectin on the osteogenesis of bone marrow and
periosteum cells were studied. Results showed that more extracellular matrix and calcium
minerals were deposited in cultures on the artifical osteoid layer than on conventional 2D
plastic; and that polarity of cell density distribution occurred in cultures on the artifical
osteoid layer while not on 2D plastic; and that there was no significant difference of the
osteogenesis between the cultures of bone marrow cells and periosteum cells.
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CHAPTER I
INTRODUCTION

Damage to weight bearing bones either due to pathologies or trauma is a common
occurrence and represents a significant problem in orthopedics [1, 4]. Large-sized bone
defects and recalcitrant fractures often require surgical intervention using grafting
materials to provide the best potential for healing. More than 500,000 bone-grafting
procedures are performed annually in the United States as well as 1.2 million worldwide.
For the average procedure, the initial surgical cost is around $20,000 US [4]. Therefore
around 10 billion dollars in United States and 24 billion dollars worldwide are expended
annually to treat large-sized bone damage. Among the bone grafts used in these
procedures, about 55% are autografts and 35% are allografts [4, 39, 69]. The limitations
of these two grafts are that (1) autografts are not always available and require a second
operation, and (2) allografts are sometimes susceptible to disease transmission from
donor to recipient. The other 10% bone graft substitutes include metals, natural and
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synthetic polymers, ceramics and composite materials [66]. The criteria for the success of
bone graft substitutes to regenerate new bone are: (1) biocompatibility, (2)
osteoconductivity – permitting cells to attach, proliferate and migrate and allowing
nutrient-waste exchange and vessel penetration, (3) osteoinductivity – inducing the
osteoprogenitors to differentiate into osteoblasts, and (4) osteogenicity – producing
mineralized tissue matrix [1, 4, 28, 39, 95]. Unfortunately, not all of existing substitutes
satisfy all of the criteria required to regenerate substantial amounts of new osseous tissue.
Therefore new bone graft substitutes still need to be designed and generated to fully
match these criteria. Bone tissue engineering provides a promising new approach to
generate novel graft substitutes combining cells, scaffolds, growth factors and mechanical
loads that should satisfy all of the above criteria in a cost effective manner [1, 4, 28, 29,
33, 39, 51, 75, 95].
An underlining premise of bone tissue engineering is to mimic key aspects of the in
vivo microenvironment as best as possible within in vitro bioreactor culture systems.
Several laboratories are developing bone culture systems in attempts to generate
functional bone tissue in vitro using tissue engineering principles [6, 22, 30, 33, 49, 50],
though none of them have been able to generate cortical bone tissue in a bioreactor
system. This is in stark contrast to ample formation of functional cortical bone tissue in
vivo. We surmise from this discrepancy that there must be some key attributes lacking in
current in vitro bone bioreactor systems which are necessary for bone cells to behave as
they do in vivo.
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One attribute that still needs to be addressed is hydraulic permeability of cortical
bone. Permeability is defined as the ease with which a fluid passes through a porous
material and can be determined from Darcy’s Law [69, 74]. The permeability of cortical
bone is important for nutrient and growth factor transport, and waste product exchange.
This places permeability critically important to maintain osteocyte viability and regulate
the physiological processes of bone remodeling and homoestasis [17, 69].
Secondly, osteoid is the densely packed organic matrix secreted by mature surface
osteoblasts that eventually becomes mineralized and forms bone tissue [9, 44].
Osteoblasts express receptors that engage two key molecules in osteoid, type I collagen
and fibronectin. These receptors modulate interactions that have been reported to promote
the process of osteogenesis [22, 27, 30, 33, 54, 62, 65, 87, 92, 93]. Thus the permeability
of cortical bone and the assembly of an osteoid layer may be important for osteoblasts to
optimize the formation of bone tissue in vivo. Accordingly, this dissertation will focus on
cortical bone permeability and the interaction of osteoblasts with osteoid as two potential
attributes that need to be investigated in a tissue engineering approach to form functional
cortical bone tissue in vitro. The following chapters of this dissertation will focus on
testing these attributes.
Chapter III-- Stainless steel and poly(methyl methacrylate) (PMMA) are commnonly
used in orthopaedic procedures [66]. They were selected as candidate scaffold materials
to be used in bone tissue engineering since they are inexpensive materials that can be
fabricated in varying shapes and exhibit acceptable biocompatibility. Still their
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mechanical properties (elastic modulus, ultimate tensile strength) and hydraulic
permeability need to be investigated in order to choose those scaffold materials that best
mimic key cortical bone properties. In addition, their biocompatibility needs to be tested
by culturing bone cells on these scaffold materials.
In Chapter III, we proposed that (1) stainless steel and PMMA could be
manufactured to exhibit similar pore size, permeability and mechanical properties as
cortical bone, and (2) stainless steel and PMMA would exhibit sufficient biocompatibility
in the cultures. To test the first hypothesis, the pore size, permeability and mechanical
properties (elastic modulus, ultimate tensile strength) of stainless steel and PMMA were
measured and compared with authentic cortical bone. To test the second hypothesis, for
short term biocompatibility test, the cell attachment percentage and proliferation of UMR
osteoblastic cells cultured on PMMA and stainless steel scaffolds for 14 days were
compared with cultures on conventional plastics. Also, for long term biocompatibility
test, MC-4 pre-osteoblasts and periosteum- derived primary bone cells were cultured on
stainless steel scaffolds for 25 days and the cell morphology and cell numbers were
analyzed by histology and histomorphometry.
Chapter IV-- The permeability of cortical bone still needs to be accurately measured
since few studies have experimentally measured the hydraulic permeability of adult
cortical bone. In addition, there are no reports in the literature establishing what chemical
components of cortical bone tissue regulate its hydraulic permeability. Knowledge
regarding the permeability of cortical bone and the chemical components that may affect
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cortical bone permeability is needed to help select scaffold materials that best mimic this
property of cortical bone. Ultimately we intend to use this information in order to
promote functional cortical bone tissue formation in vitro. Therefore, studies were
completed to (1) accurately measure the permeability of adult cortical bone, and (2)
determine the contribution of lipids and densely packed collagen matrix to the
permeability of cortical bone.
In Chapter IV, we hypothesize that: (1) the presence of hydrophobic molecules
within the porous compartment of cortical bone would reduce its permeability, and that
removal of such hydrophobic materials would increase its permeability; and (2) the
presence of a densely packed pericellular matrix (mostly type I collagen) within the
porous compartment of cortical bone would reduce its permeability, and that removal or
loosening of such collagen matrix would increase its overall permeability. To test these
hypotheses, a new device with a detection limit of 4 x 10-17 m2 was designed to
sequentially measure radial hydraulic permeability of the cortical bone wafers (1.5 mm
thickness), before and after removing lipids, and digesting with bacterial collagenase.
Confirmation of lipid extraction was done using gas chromatography and mass
spectroscopy, while collagen digestion was monitored by a colorimetric method to
measure hydroxyproline.
Chapter V-- Nutrient and waste product transport in bone tissue are controlled by
both hydraulic permeability (a measure of the ability of a material to transmit fluids) and
molecular diffusion (a net transport of molecules from a region of higher concentration to
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one of lower concentration by random molecular motion). Knowing which property has a
greater influence on nutrient transport in cortical bone tissue should aid in the selection of
appropriate scaffolds for bone tissue engineering. Therefore, In Chapter V, the diffusion
coefficient of glucose in cortical bone in radial direction was measured with diffusion cell.
And a mathematical model was established to calculate the glucose concentration profile
in the cultures with the scaffold material.
Chapter VI-- As previously mentioned, the presence of osteoid in long bone surfaces
may be an important characteristic that needs to be mimicked in vitro in order to promote
optimal osteogenesis leading to functional bone tissue formation. Osteoid is composed of
collagen fibers and several non-collagenous proteins. The predominant fibrillar collagen
in osteoid is type I collagen. In addition, an important matricellular protein, fibronectin, is
found in the osteoid layer and is required for osteoblast differentiation and vitality.
Therefore in Chapter VI, we attempted to mimic this osteoid structure with a 3-D
hydrogel made of native type I collagen and fibronectin. The osteogensis of different
types of natural osteoprogenitor cells (bone marrow and periosteum derived cells) were
measured on these 3D hydrogels and compared with conventional 2D plastic culture
dishes. In this system the following hypotheses were tested: (1) osteo- progenitors
derived from bone marrow and periosteum cells exhibit equivalent osteogenesis; (2) cell
morphology at different stages of osteogenesis would be different; (3)more extracellular
matrix would be deposited in the cultures of both periosteum and bone marrow cells on
collagen-fibronectin hydrogels compared with cultures on conventional plastic, and a
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more basal lateral deposition pattern of extracellular matrix would be observed collagenfibronectin hydrogel cultures while less so on conventional plastic; (4) and more mineral
would be deposited in cultures of periosteum and bone marrow cells on collagenfibronectin hydrogels compared with cultures on conventional plastic, and a more basal
lateral deposition pattern of mineral would be observed in collagen-fibronectin hydrogel
cultures while less so on conventional plastic. To test these hypotheses, bone marrow and
periosteum cells were cultured both on 3D collagen fibronectin hydrogels and 2D plastic.
The amount and distribution of extracellular matrix (Bone sialoprotein (BSP) and Sereted
protein acid rich with cysteines (SPARC)) and calcium mineral deposited in the cultures
were measured by histomorphometry.
Chapter VII-- This chapter summarizes the novel findings from my investigations. It
attempts to explain the limitations of these findings, provides conclusions stemming from
these findings and discusses the physiological and tissue engineering relevance of the
findings. Finally, comments are made on the next level of investigation that would
logically build on these current data for future experimentation.
In all our approach and system design may provide a means for studies to be
conducted towards the development of functional bone tissue in vitro. Our ultimate goal
is to generate a functional bone tissue on a biocompatible scaffold, which will be peeled
off from the scaffold and used as bone scaffold material to treat large size bone defect.
The contents included in this dissertation provide the first step (scaffold and cell source
selection) to develop the model system. And in the future growth factors and/or

7

biophysical stimuli will be incorporated into this system to promote sustained bone
formation in vitro.
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CHAPTER II
BACKGROUND

2.1 Overview of Bone Tissue Engineering
Bone damage due to pathologies or traumas is a common occurrence and the repair
of this damage represents a major concern in orthopedics. Large size defects in load
bearing bones with limited healing capacity often require graft intervention to provide the
best potential for healing [4, 39]. The choices of bone graft include autografts, allografts
and synthetic bone graft substitutes. Autografts, bone tissue taken from another part of a
patients’ own body (e.g., grafts taken from the patient’s iliac crest) set a gold standard for
bone graft choices. A patient’s overall health and the pain and morbidity of a second
operation site restrict autograft applications. Allografts are bone tissues taken from
cadavers. In addition to a limited availability, allografts involve the risk of blood-borne
diseases and must be correctly donor-receiver immune matched [4, 28, 95]. Synthetic
bone grafts are readily available, but from a mechanical aspect, they do not have the same
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toughness and stiffness properties as cortical bone. From a biocompatibility aspect, some
synthetic grafts lack either osteoconductive or osteoinductive properties [1, 28].
Therefore new bone graft substitutes with improved osteogenic properties are still needed.
To these ends, one approach is bone tissue engineering, which may produce variably
sized bone graft substitutes in the laboratory using a patient’s own source of bone cells
from either periosteum [30, 39,, 42, 89], or bone marrow [5, 6, 13, 33, 39, 50, 51, 76-79].
Tissue engineering is “an interdisciplinary field of research that applies the
principles of engineering and life sciences towards the development of biological
substitutes that restore, maintain, or improve tissue function”[29]. For bone tissue
engineering an underlining premise is to mimic essential aspects of the in vivo bone tissue
microenvironment as best as possible in an in vitro culture environment. Four different
parameters affecting bone tissue engineering need to be investigated and optimized: bone
cells, scaffold materials, growth factors and mechanical load [29, 33, 66].
2.2 Bone
Bone is a living, highly vascular and dynamic mineralized connective tissue. It is
characterized by it hardness, growth mechanisms, resilience and its ability to remodel and
repair itself with high fidelity [9]. Its four main components are bone matrix, bone cells,
bone marrow and its associated vascular network (Figure 2-1). Bone tissue matrix is
comprised of organic and inorganic molecules. This biocomposite nature provides
mechanical strength and a mineral store for the body [9, 17]. Various types of bone cells
form (osteoblast), maintain (osteocytes), or resorb (osteoclast) this tissue matrix [9]. Bone
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marrow, periosteum and associated vasculature provide sources of osteogenic stem cells.
At the organ and tissue levels, bone is subjected to dynamic mechanical deformation.
Mechanical stress or “load” has important consequences for the health of this tissue since
bone loss occurs in the absence of mechanical load. The physiological range of
mechanical

strains

in

cortical

bone

tissue

is

0.04~0.3%

[17,

23,

31].

Figure 2-1 Hematoxylin and eosin (H&E) staining image of tibial
diaphysis from a juvenile rat. A: Periosteum fibrous layer. B: Osseous
cambium layer, done in Midura lab
The formation of bone during the fetal stage of development occurs by two general
processes: intramembranous and endochondral ossification [9]. Intramembranous
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ossification mainly occurs during formation of the flat bones of the skull; the bone is
formed directly from mesenchyme tissue without a cartilaginous intermediate.
Endochondral ossification, on the other hand, occurs in long bones, and forms using a
cartilage tissue template. Remodeling is the process of resorption followed by
replacement of new bone with little change in shape and occurs throughout a person's life
[9]. Osteoblasts and osteoclasts, coupled together via paracrine cell signalling, are
referred to as bone remodeling units. The purpose of remodeling is to regulate calcium
homeostasis, repair micro-damaged bones (from everyday stress) but also to shape and
sculpture the skeleton during growth. Bone resorption is done by osteoclasts [9].
Bone formation is done by osteoblasts through secretion of osteoid, which is
stimulated by the secretion of several hormones and growth factors including growth
hormone, thyroid hormone and the sex hormones (estrogens and androgens) [9]. Osteoid
is the densely packed organic matrix that eventually becomes mineralized and forms bone
tissue. Osteoid is composed of collagen fibers (mainly type I collagen) and several noncollagenous proteins (such as fibronectin). Receptors expressed on osteoblasts can
interact with the molecules in the osteoid layer to promote the process of osteogenesis [9].
Moreover, the osteoid layer is always deposited underneath the osteoblast (basal
deposition pattern). This basal deposition pattern is important for osteoblasts to continue
to form new cortical bone to widen the girth of long bone shafts [9]. This pattern may
influence the packing and assembling of extracellular matrix deposited by osteoblasts,
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and thereby influences the interactions of matrix receptors on osteoblasts and their
extracellular matrix molecules, ultimately influencing the entire osteogenesis process [9].
2.3 Cells used in bone tissue engineering field
Sources of cells used in bone tissue engineering includes mesenchymal stem cells
derived from different tissues, such as bone marrow, periosteum, human umbilical cord
blood[5, 6, 13, 29, 30, 33, 39, 42, 50, 51, 76-79, 89], and mature osteoblast cells, such as
primary cells from human trabecular bone obtained during iliac crest biopsies [60].
Mesenchymal stem cells are mostly used in tissue engineering since compared to mature
30 osteoblasts cells, they proliferate quicker and have longer population doubling limits
[66]. Specifically, mesenchymal stem cells from bone marrow and periosteum are two
sources widely used by investigators.
Bone marrow is the highly cellular tissue found in the medullary cavity of long
bones (Figure 2-1) [9]. Cells from bone marrow comprise a heterogeneous group of
phenotypes including hematopoietic stem cells, mesenchymal stem cells and endothelial
stem cells [9]. Mesenchymal stem cells, a source of primary cells used in bone tissue
engineering, can be separated from the other two stem cell populations by a colony
forming adhesion assay [66]. Studies have shown the osteogenesis potential of bone
marrow cells. For example, Barralet et al. cultured bone marrow cells on type I collagen
gels for 21-28 days and showed new osteoid-like tissue formation by these cells [6].
Sikavitsas et al. cultured bone marrow cells in a flow perfusion bioreactor and showed
that such a fluid-flow bioreactor culture system minimized diffusion constraints and
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provided mechanical stimulation to the bone marrow cells, leading to the accumulation of
a cancellous bone-like mineralized tissue [78]. Although these studies demonstrated the
osteogenic nature of these cells, they were not able to generate cortical-bone like tissue in
vitro.
Periosteum is the layer of cells that lines the outer surface of all bones, except at
the joints of long bones (Figure. 2-1).[9] It consists of an irregular type of dense
connective tissue and is divided into an outer "fibrous layer" and inner "cambium layer".
The fibrous layer contains fibroblasts, adipocytes, and blood vessels, while the cambium
layer contains osteo-progenitor cells which develop into osteoblasts.[9] These osteoblasts
are responsible for increasing the width of a long bone and the overall size of other bone
types. Osteo-progenitor cells within the periosteal cambium layer can be isolated, which
provides another source of primary osteoblastic cells for bone tissue engineering [30, 89].
Several studies have reported on the osteogenic properties of periosteal cells. Wiesmann
et al. cultured periosteal derived osteoblasts on Petri dishes as well as within 3D collagen
constructs. They showed that these cells can form ‘bone like’ mineral deposits in both 2and 3-D environments and formed an extracellular matrix containing osteocalcin, SPARC
(osteonectin), and newly synthesized collagen type I in both environments [89].Koshihara
et al showed that periosteum cells are osteoblastic cells and could differentiat into
osteocytes and deposited calcified mineral in response to 1, 25 dihydroxyvitamin D3 [48].
2.4 Scaffolds used in bone tissue engineering
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One of the four key elements in bone tissue engineering is a scaffold. The gold
standard used in bone tissue engineering is autograft. Generally speaking, the criteria for
selecting a scaffold includes[4, 30, 66 95]: (1) biocompatibility, (2) osteoconductivity –
permitting cells to attach, proliferate and migrate and allowing nutrient-waste exchange
and vessel penetration, (3) osteoinductivity – inducing osteoprogenitors to differentiate
into osteoblasts, and (4) osteogenicity – producing ample amounts of mineralized tissue
matrix. Besides these criteria, there are two more issues to be considered: (1) they should
have similar mechanical properties as bone tissue; and (2) they should have similar
hydraulic permeability as bone so that they can have proper nutrient/waste product
exchange rates.
Currently many kinds of materials have been used in bone tissue engineering, which
include demineralized allograft bone matrix, ceramics and ceramic composites [4, 30],
collagen-mineral composites [86], bioactive glass [52], synthetic biodegradable polymers
[108] and metals [3]. Demineralized allograft bone matrix is a biologically derived
material exhibiting both osteoconductive and osteoinductive properties. Yet it lacks
stiffness and in some cases may cause an immune-reaction [39, 66, 95]. Ceramics and
ceramic composites are synthetic materials exhibiting osteoconductive properties and
have a similar stiffness as that of bone. Yet they are limited by a lack of osteoinductivity
and do not exhibit the same elastic modulus as that of bone [39, 66, 95]. Collagenmineral composites are matrices that exhibit the advantages of ceramics and
demineralized allograft bone matrix, but still do not exhibit the same elastic modulus as
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that of bone [39, 66, 95]. Bioactive glass exhibits both osteoconductive and
osteoinductive properties, but does not have the same stiffness or toughness of bone [39,
66, 95]. Synthetic polymers exhibit osteoconductive properties and are biodegradable [39,
66, 95]. Yet, several such polymers can elicit metabolic side effects as they decompose to
monomers. Metals, such as stainless steel or titanium, exhibit osteoconductive but no
osteoinductive properties [39, 66, 95]. Thus the selection of an optimal bone scaffold
material has not reached a single consensus and still requires careful consideration.
2.5 Biophysical stimuli used in bone tissue engineering
At the organ and tissue levels, bone is subjected to dynamic mechanical deformation
[17]. Mechanical stress or “load” has important consequences for the health of bone
tissues [12, 16, 17]. Studies have shown that in vitro, application of dynamic mechanical
forces influence bone cell proliferation and osteogenesis [33, 34, 50, 81]. Two different
mechanisms have been investigated for explaining a bone cell’s response to mechanical
load. One states that mechanical load drives nutrient and metabolite transport within bone
tissue via fluid flow [18]. Such induced fluid flow can generate streaming potentials
caused by fluid moving back and forth across fixed charges in the tissue matrix that
generate electrical potentials. These streaming potentials are thought to play an important
role in modulating bone cell activity [18, 33].
Another mechanism states that mechanical load is sensed directly by
mechanoreceptors on the surface of bone cells leading to intracellular signaling in a
manner referred to as the mechanotransduction pathway [32]--one common pathway for
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force transmission is via the focal adhesions. Transmembrane proteins including
mechanosensitive ion channels and signaling molecules such as integrins, form focal cell
adhesions with the extracellular matrix. These focal adhesions constitute a primary
pathway for intracellular force transmission and therefore have been viewed as likely
candidates for an initiating mechanosensing event. On the intracellular side, many
proteins tend to localize to focal adhesions, binding directly to either the α- or β-subunits
of the integrin heterodimer. Other proteins link integrins to the actin cytoskeleton, having
binding domains for both integrins and actin. Cell-cell junctional complexes and cellmatrix interactions transmit mechanical stimuli to the internal cellular structures via
cytoskeletal components. Some pathways of mechanotransduced signals lead to gene
activation at the nucleus via nuclear junctions [32].
In vitro, mechanical loads are applied by an actuator device in a bioreactor system.
Ideally, a bone tissue engineering bioreactor system should support rapid and orderly
development of functional bone tissue by providing control over the entire cellular
microenvironment (eg., temperature, pH, osmolality, levels of oxygen, nutrients,
metabolite and regulatory molecules) [66, 78]. Such control would facilitate mass transfer
to and from cells, and provide physiologically relevant stimuli and signals (eg., streaming
potentials, mechanotransduction) [69]. Different bioreactor designs have been used in
attempts to make tissue-engineered bone utilizing different scaffold materials and bone
cell sources, and these designs include spinner flasks, rotating wall vessels, flow
perfusion and mechanical loading devices [77, 78]. Mauney et al. applied mechanical
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loads in a 3-D bioreactor system and showed that mechanical stimulation significantly
reduced apoptosis and improved osteocyte viability in human bone tissue samples
obtained from human patients [50]. Gomes et al. cultured bone marrow cells on porous
fiber mesh scaffolds obtained from a blend of starch and poly(-caprolactone) in a fluid
flow perfusion bioreactor. They showed that levels of alkaline phosphatase activity were
higher in flow cultures compared to static ones, and that pore-like structures were formed
within the extracellular matrix which were not observed in static cultures [25]. Meinel et
al. cultured bone marrow derived mesenchymal stem cells in spinner flasks and observed
that a dynamic flow environment upregulated their osteogenesis [51]. Yu et al cultured
rat calvarial osteoblast cells in a dynamic flow culture system using high-aspect-ratio
rotating vessel bioreactors and 3D scaffolds. They showed that a 3D dynamic flow
environment affected bone cell distribution, enhanced osteogenic gene expression and
increased the production of a mineralized matrix compared to static conditions [94].
Sikavitsas et al. cultured bone marrow stromal cells in spinner flasks and demonstrated
enhanced cell proliferation at the end of the first week in spinner flasks as compare to
static cultures [79].
2.6 Our proposed bone model system
Native cortical bone can be separated into three layers: periosteum tissue layer, osteoid
layer and bone tissue layer (Figure 2-2). In our tissue engineering bone system, we
attempt to mimic these three layers in order to promote bone formation in vitro as
described in Figure 2-2. Specifically, periosteum tissue layer will be mimicked by
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isolated bone marrow or periosteum cells since these two cell types are primary bone
cells and exhibit osteogenesis in vitro. The osteoid layer will be mimicked by a native
type I collagen gel and fibronectin coating, as type I collagen is the main component in
bone extracellular matrix, and fibronectin is an extracellular matrix protein with a
collagen binding domain. Fibronectin also promotes bone cell adherence, proliferation
and osteogenic differentiation. The bone layer will be mimicked by a long term
biocompatible scaffold material with similar mechanical and permeability properties as
cortical bone.

Figure 2-2 Cortical bone tissue engineering system.
2.7 Summary
In summary, to build our bone model system, firstly the selected scaffold should
have similar mechanical and permeability properties as cortical bone, and should be
biocompatible; therefore the mechanical, the permeability and biocompatible properties
of PMMA and stainless steel were investigated in Chapter III. Secondly, the contribution
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of bone components to its permeability can be used to modify the permeability scaffold to
obtain the similar permeability as bone; therefore the permeability of cortical bone and
contribution of lipids and collagen matrix to its permeability were investigated in Chapter
IV. Thirdly, nutrient supply was important issue to be considered in culture system and
diffusion was the only way for the glucose transport in the static culture system; therefore
the diffusion coefficient of glucose in cortical bone was investigated and a mathematical
model was established to predict the glucose concentration profile in the static culture
system in Chapter V.

Fourthly, osteoid layer was bone mineralization front and

promoted osteogenesis in vivo; therefore an artificial osteoid layer made of type I
collagen and fibronectin was investigated as a culture condistion to promotes the
osteogenesis in vitro culture system in Chapter VI. Fifthly, osteoblasts derived from
periosteum and bone marrow tissues showed their osteogenesis in vitro culture system; to
select cells used in the model system, osteogenesis of these two cell types were
investigated in Chapter VI.
In all our approach and system design may provide a means for studies to be
conducted towards the development of functional bone tissue in vitro. Specifically, our
design incorporates the use of a biocompatible bone–like scaffold layer coated with a
bioartifical “ osteoid” layer of type I collagen and fibronectin, and primary osteogenitor
cells as our first step to develop bone tissue in vitro. Based on this, in the future we may
incorporate growth factors and/or biophysical stimuli into this system to promote
sustained bone formation in vitro.
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CHAPTER III
PROPERTIES OF PMMA AND STAINLESS STEEL SCAFFOLDS

3.1 Introduction:
Scaffold is one of four components (cells source, scaffolds, growth factors and
biophysical stimuli) that needs to be considered in bone tissue engineering. Key criteria
for choosing appropriate biomaterials as scaffolds to be used in cortical bone tissue
engineering are: (1) they should have similar mechanical properties as bone so that they
can restore immediate mechanical function; (2) they should have similar permeability as
authentic bone to maintain proper nutrient/waste product exchange rates; and (3) they
should exhibit full biocompatibility so that they do no harm to surrounding cells and
tissues in a patient [39, 66, 95].
Elastic modulus and ultimate tensile strength are two parameters used to evaluate the
mechanical properties of bone [17]. An elastic modulus, or modulus of elasticity, is the
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mathematical description of an object or substance's tendency to be deformed elastically
when a force is applied to it. The elastic modulus of an object is defined as the slope of its
stress-strain curve in the elastic deformation region [17]. Stress is the force causing the
deformation divided by the area to which the force is applied; and strain is the ratio of the
change caused by the stress to the original state of the object. Tensile strength is the stress
at which a material breaks or permanently deforms [17]. Ultimate tensile strength is the
maximum stress a material can withstand when subjected to tension, compression or
shearing. It is the maximum stress on the stress-strain curve [17].
The permeability of cortical bone is the measurement of the ease of fluid flow

P =
through cortical bone and can be determined by Darcy’s law:

µ Lv
A ∆ p . Here, P

(m2) is the hydraulic permeability of the material, µ (1 cp = 0.001 kg / (m·s)) is the
viscosity of the fluid flowing through the material, L (mm) is the thickness of the material,
v ( mL / hr) is the fluid flow rate, A (mm2) is the area fluid flowing through, ∆p (kpa) is
the pressure difference between upstream flow and downstream flow.
The definition of biocompatibility has been refined over the last sixty years from “do
no harm” to that of being clinically beneficial [28]. In 1940, an early definition of
biocompatibility was to be ‘non-toxic, non-immunogenic, non-thrombogenic, noncarcinogenic, non-irritant’ [28]. In 1987, biocompatibility was redefined as ‘the ability of
a material to perform with an appropriate host response in a specific situation’[28]. The
current definition (2008) of biocompatibility is the ‘ability of a biomaterial to perform its
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desired function with respect to a medical therapy, without eliciting any undesirable local
or systemic effects in the recipient or beneficiary of that therapy, but generating the most
appropriate beneficial cellular or tissue response in that specific situation, and optimizing
the clinically relevant performance of that therapy’ [28].
Different biomaterials have been used in bone tissue engineering. They include
metals (such as cobalt-chromium alloys, stainless steel and titanium), synthetic polymers
(such as PMMA), ceramics, natural collagens and their bio-composites [39, 66, 95]. In
the mid 1920’s, 316 L stainless steel was developed for surgical implants due to its higher
stiffness and higher resistance to corrosion in vivo [20]. As of today 316 L stainless steel
is still widely used in the field of orthopaedic applications since it has acceptable
biocompatibility and physical properties, and can be fabricated into a variety of shapes
and sizes for wires, screws and implants [3, 11]. Several studies have been done on the
biocompatibility of stainless steel. Puleo et al. [61] showed that stainless steel exhibits
good short term biocompatibility. However, Jocobs et al.[36] stated that 316 L stainless
steel containing chromium (16-18%) and nickel (10-14%) was a probable source of longterm complications, and their findings suggested caution for its use as an implant. Kraft et
al. reported that stainless steel wear debris had a marked and persistent negative effect on
leukocyte-endothelium interaction leading to chronic low levels of inflammation [41].
Bailey et al. also reported an immune response of the body to wear debris from stainless
steel [3]. There is still no full agreement on the biocompatibility of stainless steel,
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presumably which may because of the difference in manufacture process and the
concentration of its heavy metal components (such as chromium and nickel).
PMMA is another biomaterial widely used in bone tissue engineering since it also
exhibits acceptable biocompatibility and is easily to be manufactured [66]. The
biocompatibility of PMMA has also been called into question. Chiu et al. showed that
PMMA inhibits the proliferation and osteogenic differentiation of bone marrow cells
suggesting that PMMA may not always exhibit high levels of biocompatibility [13]. In
contrast, Ramachandran et al. showed that osteoblasts exhibited phenotypic stability
when cultured on PMMA suggesting that PMMA exhibits adequate biocompatibility [63].
In this part of my study I addressed the selection of a suitable biomaterial as a bone
scaffold in attempts to mimic cortical bone properties that may promote bone formation
in our bioreactor design. As mentioned in previous chapters, a suitable biomaterial should
have similar permeability and mechanical properties as cortical bone, and should be
biocompatible in long term cultures. Stainless steel and PMMA were selected as
candidates since they are relatively inexpensive to fabricate into any desired size and
porosity, are stiff materials and are biocompatible. Therefore I hypothesized that (1)
stainless steel and PMMA could be manufactured to exhibit similar porosity,
permeability and mechanical properties as cortical bone, and that (2) stainless steel and
PMMA would exhibit sufficient biocompatibility in cultures. To test the first hypothesis,
the porosity, permeability and mechanical properties (elastic modulus, ultimate tensile
strength) of stainless steel and PMMA were measured and compared with cortical bone.
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To test the second hypothesis, for short term biocompatibility, the cell attachment
percentage and proliferation of osteoblastic cells cultured on PMMA and stainless steel
scaffolds for up to14 days were compared with cultures on conventional tissue culture
plastic.

Also, for long term biocompatibility test, a pre-osteoblast cell line and

periosteum derived primary bone cells were cultured on stainless steel scaffolds for up to
25 days and the cell morphology and cell numbers were analyzed by H&E and DAPI
staining.
3.2 Materials and methods
3.2.1 Synthesis of PMMA Scaffolds
Described below is the protocol used to create PMMA scaffolds that have a pore size
structure that ranges from 28 -100 µm in diameter. A ‘layering’ approach utilizing
PMMA/Sodium Chloride solutions of two bead diameters (28 µm and 100 µm) was used
to create scaffolds with similar porosity property as native cortical bone.
1. Preparation of PMMA Layer Solutions
PMMA layer solutions of varying pore size were prepared as follows: (a) Solution 1
- 0.66 g of PMMA beads (bead diameter of 10-50 µm, Scientific Polymer Products, Inc.,
Ontario, NY) and 0.66 g of NaCl (sieved to 28 µm mean diameter, Scientific Polymer
Products, Inc., Ontario, NY) were combined in a 50 mL conical test tube; (b) Solution 2 0.66 g of PMMA beads (as above) and 0.66 g NaCl (sieved to 100 µm mean diameter,
Scientific Polymer Products, Inc., Ontario, NY) were combined in a 50 mL conical tube;
three tubes of solution 2 were required; and (c) Solution 3 - 0.66 g NaCl (either size)
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was placed into a fifth 50 mL conical tube. Test tubes containing solutions 1 and 2 were
mixed for 20 s with a spatula, then vortexed for 20 s, followed by incubation at 37o C in a
humidified incubator for 48 hr. The solution 3 test tube was incubated in a 60o C dry oven
for 48 hr.
2. Preparation of PMMA Scaffolds
In an airflow hood, solution 1 PMMA mixture was spread onto a clean, dry silicone
mold evenly along the surface of mold. One mL of acrylic solvent (methylene chloride
and diacetone alcohol, Craftics Plastick Acrylic Solvent Cement, Albuquerque, NM) was
added wetting the entire surface of layer. Acrylic was used to glue the layers together.
This was followed by spreading the first test tube of the solution 2 PMMA mixture
evenly over the first layer. This was followed by adding one mL acrylic solvent on top of
the second layer. Repeat the same process with the remaining two test tubes of solution 2.
Then solution 3 was spread evenly over the fourth layer of PMMA. This fifth layer was
spread and evenly distributed with a spatula. Finally the mold was put in place and a 5
pound weight placed on top of the mold cover for a 48 hr period to dry.
After 48 hr, the PMMA scaffold was removed from the mold, then the excess salt crystal
was shake off, and the scaffold was placed in a Petri dish. This was followed by a serial
washing of the scaffold, first with a 12 mL of 100% ethanol for 30 min, then with a 12
mL 70% ethanol for 30 min. Then they were placed into a 1 L beaker and washed with
Milli Q water until the conductivity of the wash water no longer changed (approximately

26

3-4 days with daily changes of the water in the 1 L beaker). At this point, the PMMA
scaffold was ready for permeability and mechanical testing.
3.2.2 Stainless Steel Scaffolds
316L stainless steel disc scaffolds with 0.750 ± 0.05 inch (1.90 ± 0.01 cm) diameter,
1/16 inch (1.5 mm) thick and 0.5 µm pore size were purchased from Mott Corporation
(Farmington, CT). The following table (Table 3-1) was the information they provided.
316L SS

Characteristics

Pore size

Thickness

Density

Porosity

Permeability

(µm)

(Inches)

(mg/cm3)

(%)

(Darcy Value )

0.5

1.5 mm

5.83

16.8

0.103

Table 3-1: Media Characterization – Mott porous 316LSS disc
*. 1) Darcy value of 1.00 = the flow of 1 cc (mL) of 1 cp (centipoise, 1 cp = 0.001 kg/(m·s)) fluid in 1
second at 1 atmosphere pressure (1atm = 101.3 kpa) through 1 cm2 x 1 cm thick section of porous
media. (1 Darcy = 9.9 x 10-14 m2, therefore, the permeability of stainless steel is 1.02 x 10-14 m2)

3.2.3 Processing for scanning electron microscope (SEM)
Scanning electron microscope (SEM) was used to view the micro-structure of
PMMA, stainless steel and cortical bone. For SEM, specimens were fixed, dehydrated
and coated with gold. In this study, stainless steel (n=3), PMMA (n=3) and cortical bone
(n=3) were submitted for SEM.
1.

Fixation.
Specimens were placed into a fixative solution (2% glutaraldehyde (EMS), 3%

sucrose (EMS), in 0.1M phosphate buffer (Cellgro) at pH 7.4) for overnight (the volume
ratio of specimen to solution was 1:20). This was followed by a serial washing of the
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specimen, first with PBS solution, 30 min each time for two times, then with milli Q
water, 5 min each time for two times.
2.

Dehydration
The specimen was dehydrated with a series of ethanol (Fisher) solutions made from

absolute ethanol (v/v) (50%, 70%, 80%, 90%, 95%, 100%, 100%), 15 min in each
solution. The specimen was then dried using a series of Hexamethyldisolazane (HMDS)
(Electron Microscopy Sciences) in ethanol solution (v/v) (1:1 HMDS-ethanol, 1:1
HMDE-ethanol, 100% HMDS, 100% HMDS, 100% HMDS), 10 min in each solution.
Then the specimen stayed in the air-flow hood for 2 hr to evaporate residual HMDS.
3.

Images taken
The dehydrated specimen was sputter coated with gold in SPI-Module Sputter Coater

(Structure Probe Inc., West Chester, PA).to increase the ability of a specimen to conduct
electricity and emit secondary electrons. Then the specimen was ready for SEM imaging.
SEM images were taken with a scanning electron microscope (SEM) (S570, Hitachi,
Japan).
3.2.4 Mechanical property measurement
The elastic modulus and ultimate tensile strength of stainless steel (sample size n=3),
PMMA (sample size n=3) and cortical bone (sample size n=3) were measured using a 4
point bending holder device. Specifically, specimens were placed in the holder, and a
mechanical load was applied on the specimen using an Instron Model 8500 tensile test
machine as depicted in Figure 3-1. The load and displacement data were recorded with
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time. The elastic modulus and ultimate tensile strength were calculated based on the load
and displacement curve generated using the standard equation as below. If we set the
dimensions

of

the

specimen

and

experiment parameters as: length = L,
width = b, height = h, the distance
between loading site = a, the load = P
and the displacement = D.
The moment of inertia (I) of the
specimen can be calculated as equation
(1);
I=

Figure 3-1 Schematic of mechanical load on
the specimen.

b×h
(1),
12
3

Strain can be calculated as equation (2)
Strain =

12 × D × h / 2
(2),
2a × (3L − 2a )

And Stress can be calculated as
equation (3)
Stress =

P × 2a × h / 2
4I

(3). Therefore,

stress-strain curves were generated
(Figure 3-2); and the elastic modulus

Figure 3-2 Stress strain curve of a specimen
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was calculated as the slope of the stress –strain curve in the elastic phase and the ultimate
tensile strength was the stress at the breaking point.
3.2.5 Permeability measurement
The permeability of stainless steel (n=3) and PMMA (n=3) was measured three
independent times in a radial flow direction using a custom built device (same as the
device used to measure bone permeability, detailed in Chapter IV). All the samples were
completely sealed in the holder and tested in the pressure range of 0 ~300 kpa. Phosphate
buffered saline (PBS) solution was pumped through the samples using a 4 MPa pressure
limit pump (Pump-P 500, Pharmacia Biotech) at 4 different flow rates (v): 10, 20, 30 and
40 mL/hr. For each flow rate, ∆p, the pressure difference of the upstream fluid and the
downstream fluid, which is atmosphere, was measured with a pressure gauge (Ashcroft
Cat # 25D1005PS 02L 100). The thickness (L) of samples was measured with digital
calipers (0.1 mm accuracy) at three different sites along the scaffold materials. Fluid flow
was assessed through a circular area (A) of 5 mm in diameter. And µ is the viscosity of
PBS solution (µ = 1cp). Permeability (P) was then calculated using Darcy’s Law shown
in Equation (1) below:

P =

µ Lv
A∆p

(1 )
.

3.2.6 Optimizing the scaffold surface for bone cell adhesion, growth and osteogenic
differentiation
All following steps were performed sterilely.
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1. Scaffold preparation

1. a. Collagen gel coating process:

Figure 3-3 SEM images of the surface structure of scaffold after collagen gel coating. the
top layer was PMMA scaffold, the bottom layer was stainless steel (SS)

Figure 3-4 SEM images of the surface structure of stainless steel scaffold after 48 hr 2
layer collagen gel coating

A 2 mg/mL rat tail type I collagen solution was prepared from a stock of native
type I collagen solution (3.56 mg/mL, Gibco). A 250 µL aliquot of the 2 mg/mL collagen
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solution was placed onto PMMA and stainless steel scaffolds in a 12-well plate sitting on
ice. Half an hour later; the plate was put into a 370 C incubator for 24 hr. Any excess
collagen gel was trimmed off with a surgical blade. For second layer coating, a second
collagen gel layer was coated onto the first layer, and the plate was put into a 370 C
incubator for another 24 hr (total 48 hr).
The surface structure of the scaffold after collagen gel coating was shown in Figure
3-3. Comparing to 24 hr one layer coating, 48 hr 2 layer coating generated the smoothest
surface structure. Also, high magnification SEM images of the surface structure of
stainless steel scaffold after 48 hr 2 layer collagen gel coating are shown in Figure 3-4. It
shows that this collagen fiber dimensions are similar as in vivo collagen fiber dimensions.
Therefore, for our biocompatibility test, the 48 hr 2 layer collagen coating process was
applied.
1. b. Fibronectin film coating
A 2 µg/mL fibronectin solution was prepared from a stock fibronectin solution (1
mg/mL in PBS (Sigma)). The scaffold coated with collagen gel layers was put into a new
12-well plate, and a 250 µL aliquot of the 2 µg/mL fibronectin solution was placed
directly onto the collagen layer on the scaffold surface. The plate was put into a 370 C
incubator, and after 2 hr incubation, the scaffold was washed with 500 µL PBS for ten
times at room temperature.
2. Short term biocompatibility test
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The osteoblast cell line, UMR106-01 BSP, was used to test the short-term
biocompatibility of the PMMA and stainless steel scaffolds. A coverslip, a conventional
culture material, was used as a positive control. Specifically, 1000 cells /mm2 cells were
seeded onto the collagen and fibronectin coated PMMA, stainless steel scaffold and
coverslip in a 12 well plate. Half a milliliter of growth medium (MEM (Cellgro)
supplemented with 10% fetal bovine serum (FBS)) was put into each culture well.
Cultures were incubated for 14 days and the medium was changed every other day. At 2
hours, three cultures from each group were taken for cell attachment analysis. At day 2, 4,
6, 8, 10, 12, 14, three cultures from each group were taken for cell number counting. The
cell number per culture was quantified based on double stranded DNA content using the
PicoGreen assay kit from the Molecular Probes. PicoGreen is a dye that binds to the
major grooves in dsDNA, and the resulting fluorescence activity corresponds to the
dsDNA concentration in solution and represents a surrogate measure of cell number.
Specifically, for one culture well, half mL PBS solution was used to wash the well; then
250 µL Lysis buffer (10 M Formamide (Fisher Scientific), 50mM Na acetate (Sigma),
1% SDS (ICN) solution at pH 6) was added into each well; then the well was incubated at
60 0C for 2 hours; after the culture was cooled down; the cells were scraped into a tube;
the tube was sonicated for 30s, now the sample was ready for DNA analysis with
PicoGreen assay kit.
At day 14, two cultures was fixed with 2% paraformaldehyde in PBS at 40 C
overnight, and then stained with 4',6-diamidino-2-phenylindole (DAPI), a fluorescent
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DNA dye that stains cell nuclei, and Rhodamine-Phalloidin, a high-affinity probe for Factin; Then confocal images were taken for morphology analysis with Leica TCS-SP
spectral laser scanning confocal microscopes. Then the images were processed with
Improvision Volocity software to generate 3D images.
3. Long term biocompatibility test
MC-4 pre-osteoblast cell line (a cell line exhibiting oteogenesis in vitro) (a gift from
R. Franceschi, Univ. of Michigan) and periosteum cells (primary bone cells) obtained
from the tibial diaphyses of 30 day old Sprague Dawley male rats were used for longterm biocompatibility tests of stainless steel scaffolds. Cells were seeded onto the
stainless steel scaffolds double coated with collagen and fibronectin at a density of 200
cells/mm2. Half a milliliter of growth medium (α-MEM (Cellgro) supplemented with
10% fetal bovine serum (FBS)) was put into each culture well. After 4 days, this growth
medium was changed to a differentiation osteogenic medium (α-MEM supplemented
with 10% FBS and 50 µg/mL L-ascorbic acid 2-phosphate (Sigma), 50 µg/mL L-ascorbic
acid (Sigma) and 10 mM β-glycerophosphate (Sigma)). Cultures were incubated for an
additional 21 days with changing the medium every day. Cells cultured on a 3-D
hydrogel made of collagen and fibronectin and 2-D tissue culture plastic served as
controls. Triplicate cultures were done for each culture condition.
At the end of the culture period, cell layers (including collagen and fibronectin layer)
were peeled off from stainless steel or culture plates and then fixed with 2%
paraformaldehyde in PBS at 40 C overnight. After fixation, samples were embedded in
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paraffin and oriented in order to cut cross-sectional slices, which would represent the top
and bottom of each culture. Seven micron slices were cut from each tissue block.
Hematoxylin and eosin (H&E) and DAPI were used to examine cell morphology and
nuclei numbers. Three slides were examined from each block.
3.2.7 Statistic analysis
Analysis of variance (ANOVA) caculations with post-hoc multiple comparison tests
(Dunn Method) were used for statistical analysis (SigmaStat software v3.5). Quantitative
results are reported as the mean ± standard deviation. Unless stated otherwise, statistical
significance was set at a p value of less than 0.05.
3.3 Results
3.3.1 Porosity of PMMA and Stainless steel scaffold

Figure 3-5 Scanning electron microscopy images of PMMA, stainless steel and
cortical bone after collagenase treatment. A: PMMA, B: stainless steel, C: cortical
bone. The red arrow points to the pores.
A semi-quantitative analysis of the SEM images of PMMA and stainless steel as
compared to rat cortical bone (lipids and collagen removed from porous part) showed that
PMMA and stainless steel had similar pore sizes (Figure 3-5). From these images, the
pore sizes of these three materials were generated: PMMA (21 ± 12 µm), stainless steel
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(18 ± 13 µm) and cortical bone (11 ± 10 µm). Based on one way ANOVA analysis
(Duncan’s method), the differences in the mean value among the groups were not great
enough to exclude the possibility that the difference was due to random sampling
variability (n=3); there was no significant difference between the pore size of these three
materials (p=0.592). A limitation of this analysis in the power of the performed test
(0.050) is below the desired power of 0.800. Despite this limitation, this analysis suggests
that both stainless steel and PMMA have roughly comparable pore size as cortical bone.
3.3.2 Stiffness of PMMA and Stainless steel
The elastic modulus of PMMA,
stainless steel and cortical bone are
shown in Figure 3-6. Comparing elastic
modulus of these three groups with one
way ANOVA (Duncan’s method), the
difference in the mean value among the
groups are greater than would be
expected by chance, there was a
statistically

significant

Figure 3-6 Elastic modulus of PMMA,
stainless steel with mean pore size of 0.5
µm and cortical bone. Mean ± SD, n = 3

difference

(P<0.001). Specifically, the elastic modulus of PMMA (1.19 GPa) was significant
smaller (10 fold) than that of cortical bone (17 GPa) (P < 0.01), and the elastic modulus
of stainless steel with mean pore size 0.5 µm (51 GPa) was significant larger (3 fold) than
cortical bone (P < 0.01). From this aspect, neither stainless steel nor PMMA exactly
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match the elastic modulus of cortical bone.
The ultimate tensile strength of PMMA, stainless steel and cortical bone are shown
in Fig 3-7. Comparing the ultimate tensile strength of these three groups with one way
ANOVA (Duncan’s method), the differences in the mean value between PMMA (21 Mpa)
and cortical bone (152 MPa), were
greater than would be expected by
chance;
significant

there

was

difference

a

statistically

(P

<

0.001).

Specifically, the ultimate tensile strength
of PMMA was significantly lower (7 fold)
than that of cortical bone. The differences
Figure 3-7 Ultimate tensile strength of
PMMA, stainless steel with mean pore
size of 0.5 µm and cortical bone. Mean
± SD, n = 3

in the mean value between stainless steel
(160 Mpa) and cortical bone (152 MPa),

was not great enough to reject the possibility that the difference might be due to random
sampling variability. There was not a statistically significant difference between these
two groups (P = 0.197). The power of the performed test (0.148) is below the desired
power of 0.800. Despite this limitation, the ultimate tensile strength of stainless steel can
be considered to be roughly similar to that of cortical bone. From this aspect, stainless
steel matched theultimate tensile strength of cortical bone, while PMMA did not.
3.3.3 Permeability of stainless steel and PMMA
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Hydraulic permeability value for PMMA, stainless steel and cortical bone are shown in
Figure 3-8. Comparing the permeability values of these three groups with one way
ANOVA

(Duncan’s

method),

the

differences in the mean values among
all the groups (PMMA (8.2 x 10-14 m2),
stainless steel (5.9 x 10-14 m2) and
cortical bone (3.05 x 10-14 m2)) were
not great enough to exclude the
possibility that the difference was due

Figure 3-8 Permeability of PMMA,
stainless steel with mean pore size of
0.5 µm, cortical bone. Mean ± SD, n = 3

to random sampling variability; there
was no statistically significant difference
(P=0.057). The power of the performed
test (0.462) was below the desired power
of 0.800. Nevertheless, the permeability
of PMMA and stainless steel were
similar

to

that

of

cortical

bone.

Accordingly, PMMA and stainless steel
can be considered to be roughly similar
to the hydraulic permeability of cortical

Figure 3-9 The percentage of attachment
of UMR cells on PMMA and stainless steel
scaffold after 2 hr, coverslip as a control.
Mean ± SD, n = 3

bone.
3.3.4 Short term biocompatibility of PMMA and stainless steel
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Cell attachment percentages of
UMR osteoblastic cells on PMMA,
stainless steel and coverslip scaffolds are
shown in Figure 3-9. Comparing the cell
attachment percentage of these three
groups

with

one

way

ANOVA

(Duncan’s method), the differences in
Figure 3-10 The growth curve of UMR
cells cultured on PMMA and stainless
steel scaffold for 72 hr. Coverslip as
control. Mean ± SD, n = 3

the mean value among all the groups
(PMMA (86%), stainless steel (98%) and
cortical bone (94%))

were not great

enough to exclude the possibility that the difference was due to random sampling
variability; there was not statistically
significant difference (P = 0.228). The
power of the performed test (0.142) is
below the desired power of 0.800.
Specifically, there was no significant
difference among osteoblastic cell
attachment percentages on PMMA,
stainless steel and that on coverslip.
Growth of UMR cells on PMMA,

Figure 3-11 The growth curve of UMR cells
cultured on PMMA and stainless steel
scaffold for 14 days. Coverslip as control.
Mean ± SD, n = 3

stainless steel and glass coverslip
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scaffolds over three day culture is shown in Figure 3-10. Comparing the DNA content per
culture at the end point, with one way ANOVA (Duncan’s method), the differences in the
mean value among all the groups were not great enough to exclude the possibility that the
difference was due to random sampling variability; there was not statistically significant
difference (P = 0.591). The power of the performed test (0.050) was below the desired
power of 0.800. Thus, to the limits of our analysis no significant difference was among
cell proliferation over three day culture period on PMMA, stainless steel scaffold and
coverslip.
The growth curve of UMR cells on PMMA and stainless steel scaffold for 14 days
is shown in Figure 3-11. A 2-way ANOVA analysis (means comparison using Tukey
Test (factor 1: time point, factor 2: culture material)) was run to compare DNA content
per culture, as culture material was concerned, the differences in the mean value among
all the groups were not great enough to exclude the possibility that the difference was due
to random sampling variability; there was not statistically significant difference
(P=0.174). The power of the performed test was 0.99. Specifically, there is no difference
between the cell proliferation of 14 days culture on PMMA, stainless steel scaffold and
that on coverslip.
Moreover, since biocompatibility is defined as ‘ability of a biomaterial to perform its
desired function with respect to a medical therapy, without eliciting any undesirable local
or systemic effects in the recipient or beneficiary of that therapy, but generating the most
appropriate beneficial cellular or tissue response in that specific situation, and optimizing
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the clinically relevant performance of that therapy’, there it is important to compare the
cell morphology and osteogenesis of osteoblastic on these material scaffold. Therefore
the confocal images of UMR cell cultures on stainless steel and coverslip scaffold were
taken (Figure 3-12). It showed that the cultures on both stainless steel and coverslip have
been multilayer; the cell nuclei and F-actin staining patterns were similar, which
suggested the similarity of the cell morphology of cultures on these two scaffolds.

Figure 3-12 Snapshot of confocal image of UMR cell cultured on stainless steel
scaffold and coverslip. DAPI staining (nuclei) is blue color, Rhodamine-Phalloidin
staining (F-actin) is red color.
In all, from the short-term cell growth tests, with limitation of that no data about the
osteogenesis of osteoblastic cells on these two scaffolds, the PMMA and stainless steel
scaffolds have roughly similar outcomes ( cell proliferation ( growth curve) nuclei
morphology (growth curve)) as glass coverslip, which is conventional used biomaterial
and exhibit good biocompatibility. Therefore, PMMA and stainless steel are considered
to be biocompatible for short-term osteoblast cultures.
3.3.5 Long term biocompatibility of stainless steel scaffold
Representative H&E staining images of sections from MC-4 and periosteum cells
cultured on collagen-fibronectin coated stainless steel, 3D hydrogels made of type I
collagen and fibronectin and 2D conventional tissue culture plastic are shown in Fig 3-13.
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These images showed that, for both MC-4 and perisoteum derived bone cells, there were
no substantial difference in the thickness of the resultant cell layer, though qualitative
difference were noted in staining intensities between cultures on collagen gel, plastic and
stainless steel scaffolds. To quantify cell numbers, DAPI staining was used to stain cell
nuclei and nuclear numbers were counted.

Figure 3-13 H&E staining of cultures on stainless steel, collagen-fibronectin
hydrogel and plastic. A-C: MC-4 cells cultured on stainless steel, collagenfibronectin hydrogel and plastic respectively. D-E: Periosteum cells cultured on
stainless steel, collagen-fibronectin hydrogel and plastic respectively. A1-F1: the 2 x
enlarged image of A-F respectively.
Representative DAPI staining images of sections from MC-4 or periosteum cells
cultured on collagen-fibronectin coated stainless steel, 3D hydrogels made of type I
collagen and fibronectin and 2D conventional tissue culture plastic are shown in Fig 3-14.
These images showed that, for both MC-4 and perisoteum cells, no significant differences
between nuclear numbers on collagen gel, plastics and stainless steel scaffold.
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Figure 3-14 DAPI staining of cultures on stainless steel, collagen-fibronectin
hydrogel and plastic. A-C: MC-4 cells cultured on stainless steel, collagenfibronectin hydrogel and plastic respectively. D-E: Periosteum cells cultured on
stainless steel, collagen-fibronectin hydrogel and plastic respectively. A1-F1: the 2 x
enlarged image of A-F respectively.
One way ANOVA (Duncan’s method) was used to compare nuclei number on collagen
gel (3.11 ± 0.56 x 103 nuclei /mm2) (n = 3), plastics (3.01 ± 0.78 x 103 nuclei /mm2) (n =
3) and stainless steel scaffolds (2.33 ± 0.33 x 103 nuclei /mm2) (n = 3). This analysis
showed that the differences in the mean values among all the groups were not great
enough to exclude the possibility that the difference was due to random sampling
variability; there was no statistically significant differences (P = 0.342). The power of the
performed test (0.078) was below the desired power of 0.800. Despite this limitation, it is
reasonable to conclude that cultures on stainless steel scaffolds, glass coverslip or
collagen- fibronectin gels yielded similar numbers of osteoblastic cells often extended
culture incubation. This suggest that 316 L stainless steel scaffolds are biocompatible for
long term bone cell culture.
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3.4 Discussion
The gold standard for selecting an optimal scaffold to be used in bone reconstruction
surgery is autograft. It then stands to reason that the selection of an appropriate scaffold
for bone tissue engineering should meet the key attributes of an autograft [66]. Generally
speaking, the key criteria for selecting a bone scaffold includes: (1) biocompatibility, (2)
osteoconductivity – permitting cells to attach, proliferate and migrate and allowing
nutrient-waste exchange and vessel penetration, (3) osteoinductivity – inducing
osteoprogenitors to differentiate into osteoblasts, and (4) osteogenicity – producing
mineralized tissue matrix[39, 66, 95]. In addition, there are two more important issues to
be considered: (1) having similar mechanical properties as bone; and (2) having similar
permeability as bone to promote proper nutrient/waste product exchange rates. Our
overall results are shown in table 3-2. It indicated that 316 L stainless steel and PMMA
could be manufactured to exhibit roughly similar pore size and permeability properties as
cortical bone. From a mechanical properties aspect, stainless steel partially matched with
cortical bone (elastic modulus) while PMMA did not match up with cortical bone.
Moreover, our results showed that a 316L stainless steel scaffold exhibited appropriate
biocompatibility both short term and long term bone cell culture. PMMA exhibited
appropriate biocompatibility for short term culture; and its long term biocompatibility
needs to be investigated in the future. Therefore, we can conclude that both PMMA and
316L stainless steel have reasonable well matched properties with cortical bone, thus
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enabling them to be used in tissue engineering systems. Based on our data, our first
choice would be 316L stainless steel, and the second choice would be PMMA.
Still there are some limitations in this study that should be addressed in future study:
(1) the long term biocompatibility of PMMA was not tested; (2) an extensive growth
curve of long term cultures; (3) extracellular matrix was not immuno- stained to
investigate if there were qualitative differences between cultures on stainless steel,
collagen fibernectin hydrogel and plastic by 25 days I culture culture; (4) Osteogensis
(suck as alkaline phosphatase activity staining, bone matrix protein, and/ or calcium
mineral staining) needs to be evaluated to determine the full biocompatibility of the
materials for bone cells; (5) the power test showed that the power was below the designed
power and in the future study the sample number should be increased to be able to
exclude random variability.
Properties

PMMA Stainless steel Cortical bone

Pore size

√

√

√

Elastic modulus

x

x

√

Ultimate tensile strength

x

√

√

Permeability

√

√

√

Short term biocompatibility

√

√

√

Long term biocompatibility

n/a

√

√

Table 3-2 The properties of PMMA and stainless steel scaffold
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CHAPTER IV
LIPIDS AND FIBRILLAR COLLAGEN MATRIX RESTRICT THE
HYDRAULIC PERMEABILITY WITHIN THE POROUS COMPARTMENT OF
ADULT CORTICAL BONE

4.1 Introduction
Hydraulic permeability of cortical bone is the measurement of the ease of fluid flow
through cortical bone. Fluid flow inside cortical bone is critically important for nutrient
and waste product transport, which is important to maintain osteocyte viability and
regulate the physiological processes of bone remodeling and homoestasis [7, 98].
Therefore hydraulic permeability may be a key attributor that needs to be mimicked in
bone tissue engineering. Thus a study of hydraulic permeability of cortical bone and the
bone components that regulate it need to be further investigated.
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Adult cortical bone tissue is a biocomposite material which is composed of 67%
mineral salts and 33% organic matrix by dry weight containing 62% type I collagen, 26%
minor collagens and non-collagenous proteins, 6% lipids and 6% complex carbohydrates
[19, 60]. Based on fluid accessibility, bone tissue is separated into two generalized
compartments:

a non-porous compartment and a porous compartment comprising

90~95% and 5~10% of its volume, respectively [14]. The porous compartment contains
vascular channels (Haversian and Volkman’s canals) interconnected by a lacunacanalicular system filled with osteocytes, their filipodial extensions and a surrounding
pericellular matrix [9, 10, 15, 88]. Biological fluids flow within this porous compartment
of cortical bone thereby providing a system to exchange nutrients and metabolic waste
products [18, 52]. Since permeability of cortical bone is a measure of fluid flow through
this porous compartment, it should be affected by the tissue composition within this
compartment.
To date, few studies have experimentally measured the hydraulic permeability of
cortical bone in part because of the engineering challenges in measuring extreamly low
permeabilities. These devices require high pressure tolerances in both the bone tissue
holding chamber and other upstream components of the permeability device in order to
accurately measure the permeability of cortical bone. Li et al. measured the permeability
of adult canine versus puppy cortical bone [46].

They reported that the radial

permeability of adult canine tibial cortex was 5 x 10-17 m2 and that the radial permeability
of puppy bone was 6-fold higher than that of adult canines. In addition, they suggested
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that the periosteal portion of cortical bone was relatively impermeable as compared to the
endosteal portion of cortical bone. Though this prior study provided fairly accurate
estimations of the radial permeability of adult cortical bone, there have been no prior
reports addressing what chemical components within the porous compartment of cortical
bone are the primary contributors to these low permeability values. To select a bone
tissue engineering scaffold with similar permeability properties as cortical bone, we need
to first measure the permeability of cortical bone. Also, investigating the contributions of
select components to bone permeability will help us to modify existing scaffold to obtain
similar permeability level. Therefore, in this Chapter we designed a device to assess
radial hydraulic permeability of cortical bone that enabled us to make repeated measures
on the same bone tissue wafers before and after sequential chemical or enzymatic
treatments. This enabled us to test two hypotheses: (1) the presence of hydrophobic
molecules within the porous compartment of cortical bone would reduce its permeability,
and that removal of such hydrophobic materials would increase its permeability; and (2)
the presence of a densely packed pericellular matrix (mostly type I collagen) within the
porous compartment of cortical bone would reduce its permeability, and digestion of the
collagen fibers would increase its overall permeability. To test the first hypothesis,
acetone-methanol (or zwitterionic detergent) was used to remove lipids from the porous
compartment of cortical bone and assess contribution of lipids to the hydraulic
permeability of cortical bone. Bacterial collagenase and dispase were used to digest
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fibrillar collagens in the porous compartment of cortical bone and assess the contribution
of collagen matrix to the hydraulic permeability of cortical bone.
4.2 Material and Methods
All bone tissues were obtained from animals that had been sacrificed in the course of
IACUC approved research investigations conducted elsewhere at this institution. Middiaphyseal portions of tibia were harvested from adult outbred canines (~25-30 kg body
weight). Periosteal tissue layers, including most of the basal cambium cell layer, were
stripped off the bone by dissection. Bone marrow was flushed out of the bone with
phosphate buffer saline (PBS) (Cellgro). These tibial diaphyses were then stored in PBS
with 0.05% sodium azide (Sigma) at 4° C and used within a 2 week period from
collection. Thin sections were cut from these tibial diaphyses in a cross-sectional plane
and stained with basic fuchsin to reveal the patterns and orientation of Haversian and
Volkman’s canals. Such histological analysis revealed that the presence and orientation
of Haversian and Volkman’s canals were different in the periosteal versus the endosteal
halves of the canine cortical bone (Fig 4.1A). In the periosteal half there appeared to be
fewer Volkman’s canals compared to the endosteal half. In the endosteal half, some of
these channels traversed radially throughout its entire width. Thus, in agreement with the
assessments by literature [51], the endosteal halves seemed to be more amendable for
radial hydraulic permeability measurements than their corresponding periosteal halves.
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Figure 4-1 Selection of bone tissue regions and the means to measure hydraulic
permeability of cortical bone. Panel A shows a representative histology image of a
cross section of canine tibial diaphysis. Panel B illustrates the sampling of cortical
bone specimens along the tibial diaphysis length. Shaded areas represent the bone
wafer tested. Panel C: The schematic of the device used for measuring permeability
(dimensions of this device refer to appendix 1).
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Figure 4-2 Images of the devices for cutting bone and measuring bone
permeability. A: Canine tibia. B. EXTEC ® Labcut 1010 Low Speed Diamond Saw
(EXTEC Corp). C. Bone wafers. D. Bone holder. E. Overview of the permeability
device. F. Pump-P 500
Based on the above histological findings, this study focused on measuring radial
hydraulic permeability of bone wafers from the endosteal halves of these adult canine
tibial diaphyses. Endosteal bone wafers from the medial and lateral aspects of the
diaphyseal cortex (over the entire superior to inferior axis, see shaded regions in Fig 4.1B)
were separately collected and, if not analyzed immediately, then they were stored in PBS
with 0.05% sodium azide in pre-weighed glass bottles. Bone wafers with dimensions of
~20 mm length, ~15 mm width, and 1.5 mm thick were cut from the diaphyseal portions
of tibial cortices with an EXTEC ® Labcut 1010 Low Speed Diamond Saw (EXTEC
Corp) (Fig 4.2A-C). The permeability of each fresh bone wafer was measured three
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independent times in a radial direction using a customized device (Fig. 4.1C (dimensions
of this devices in appendix 1), Fig 4.2D-F). The bone holder device was modified from
Standard-Wall (Schedule 40) White PVC Pipe Fitting (1/2" Pipe Size, Female Union,
pressure limit 150 PSI (1033 kpa). Device construction was completed in the Prototype
and Polymer Labs in the Department of Biomedical Engineering at the Cleveland Clinic.
Firstly, bone wafers were sealed in the bone holder. Then PBS solution was pumped
through the bone wafers using a pump (Pump-P 500, Pharmacia Biotech), at four
different flow rates (v): 10, 20, 30 and 40 mL/hr. For each flow rate, ∆p, the pressure
difference between the upstream fluid and the downstream fluid (atmosphere) was
measured with a pressure gauge (pressure limit 100 PSI (690 kpa)) (Ashcroft Cat #
25D1005PS 02L 100). The thickness (L) of each bone wafer was measured with digital
calipers (TRESNA, 111-102B; 0.1 mm accuracy) at three different sites along the bone
wafer surface. Fluid flowed through a circular area (A) (5 mm diameter) of the bone

P =
wafer. Permeability (P) was then calculated based on Darcy’s Law:

µ Lv
A∆p .

Here, P: permeability (m2), µ: the viscosity of PBS solution (1 cp = 0.001 kg/(m·s)), L:
the average thickness of bone wafer (mm), v: the flow rate of the flow through bone
wafers (mL/h), A: the area of flow through bone wafers, ∆P: the pressure difference
between the upstream and downstream of flow (kpa).
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Based on Darcy’s law, there is a linear
relationship between flow rate (v) and ∆p,
the

pressure

difference

between

the

upstream fluid and the downstream fluid.
The relationship between the flow rate and
pressure difference measured by our device
(for one representative sample) is shown in
Fig 4.3. It shows that a linear relationship

Figure 4-3 Relationship of flow rate and
pressure difference

(R2 = 0.9933) between these two parameters indicating it can be used to measure
hydraulic permeability of cortical bone wafers. A visible inspection of the bone provided
documentation indicating holder device at every test run lack of leakage, and in the case
of fresh or unprocessed bone wafers, no fluid flow up to 100 psi pressure.
After permeability measurements of unprocessed bone wafers were completed,
wafers were treated with 10 ml of a 1:1 (v/v) acetone-methanol (AM) (Sigma) solution at
4° C for three days (or a limited number of wafers treated with 2% (w/v) chaps [80] in
PBS solution at 4° C for 7 days) in pre-weighed glass bottles. This volume ratio of AM
solution to sample volume is estimated to be 20~30-fold volume excess. After such
treatments the bone wafers were put into new bottles and washed with 10 mL PBS
solution three times for 2 hr each time. Permeability of each AM-treated bone wafer was
measured three times independently. Proof that the AM treatments of the bone wafers
extracted lipids was sought as follows. The AM solutions in their respective sample
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bottles were placed under a nitrogen stream to evaporate the organic solvents and obtain
dried waxy residues. After evaporation, the sample bottles were weighed again and the
dry weight of lipids was obtained by taking the difference between the weight of each
bottle before and after evaporation. Lipid residues were analyzed for specific lipid
contents by gas chromatography-mass spectroscopy performed at the Kansas Lipidomics
Research Center (Manhattan, KS). Cholesterol was measured spectrophotometrically as
previously published [67].
After measuring permeability of AM-treated specimens, each bone wafer was then
treated with 5 mL of a 100 U/mL bacterial collagenase (type XI, Sigma C-9407) solution
in PBS supplemented with 10 µM 4-(2-Aminoethyl) benzenesulfonyl fluoride
hydrochloride (AEBSF) (Sigma) overnight at 37° C. AEBSF was added to inhibit the
activities of other serine proteases potentially contaminating the collagenase preps.
Following collagenase digestion, all bone wafers were washed with 10 mL PBS solution
three times for 1 hr each time. Permeability of each collagenase-treated bone wafer was
measured three times independently. Proof of collagenase activity was sought by
measuring the amounts of hydroxyl-proline released from the bone wafers into the
collagenase solution. Briefly, a 0.5 mL aliquot from each collagenase digestion reaction
was placed into Reacti –Vials (Pierce) and frozen overnight at -20° C. The frozen
solutions were vacuum dried in a Speed Vac SC110 Concentrator (Savant) for 2 hrs. The
dried residues were resuspended in 0.3 mL 6 N hydrochloric acid (Constant boiling purity
for amino acid analysis, Pierce). These vials were placed into a Reacti-Therm III heating
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module (Pierce) and heated at 105° C for 16 hrs to quantitatively release free amino acids.
After acid hydrolysis, a nitrogen gas stream was used to remove the HCl from each
sample at 37° C. Each sample was then rehydrated in 0.5 mL of Mill-Q water (Millipore),
and their hydroxyl-proline contents were measured by a spectrophotometric method [8,
81].
After measuring the permeability of collagenase-treated bone wafers, they were
treated with 5 mL of a 1.2 U/mL bacterial Dispase (Sigma) solution overnight at 37° C.
Following dispase digestion, all bone wafers were washed with 10 mL PBS solution three
times for 1 hr each time. Permeability of each dispase-treated bone wafer was measured
three times independently. Proof of dispase activity was sought by measuring the
amounts of hydroxyl-proline released from the bone wafers into the dispase solution in a
manner similar to that described above for the collagenase solution.
After measuring the permeability of dispase-treated specimens, bone wafers were
then treated with 20 mL of a 400 mM EDTA (pH 8) solution at 4° C until all of the
mineral content was removed (~2-3 weeks). Confirmation of a complete removal of the
mineral content of each specimen was obtained by X-ray micro-computed tomography
(micro-CT) imaging at an isotropic voxel resolution of 26 µm. Following EDTA
decalcification, all specimens were washed with 10 mL PBS solution three times, 30 min
each time. Permeability of each EDTA-treated bone wafer was measured three times
independently. The remaining insoluble bone organic matrix was hydrolyzed with 6N
hydrochloric acid and the total amount of hydroxyl-proline in the remaining insoluble
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tissue matrix after EDTA treatment was measured by a spectrophotometric method as
described above, and served as a measure of total insoluble collagen in each sample.
In addition, the porosity of fresh or unprocessed bone wafers was measured. Bone
wafers with dimensions of 20 mm length, ~15 mm width, and 1 mm thick were cut from
the diaphyseal portions of tibial cortices with an EXTEC ® Labcut 1010 Low Speed
Diamond Saw (EXTEC Corp). Micro-CT volumes of bone wafers (Sample size N = 6)
were acquired using a SkyScan 1172 (3 µm voxel resolution) ex vivo imaging system.
Porosity analysis was performed using Matlab R2008a (MathWorks), Image Pro-Plus
v6.1 (Media Cybernetics), VolSuite (Ohio Supercomputer Center, Columbus, OH), and
MicroView v2.2 (GE Healthcare). Bone volumes (~1800 x 1000 x 1000 voxels) were
rotated and cropped using VolSuite, and imported into Image-Pro as individual image
stacks. In each plane of a particular stack, holes were filled using a morphological
"closing" filter and bone outgrowths from the endosteal surface were removed using a
watershed filter. The resulting contiguous, "filled" bone volumes were then multiplied by
an inverted and thresholded version of their corresponding original volume to reveal
porous content that was further filtered in Matlab to remove pores below a given
volumetric threshold (connected components algorithm). Subsequently, total pore volume
and porous volumes in both the axial and radial directions were calculated (identified by
ellipitical orientation of each pore -25 to 155 degrees from vertical in the xy plane with
permeability measured along the x-axis, indicating the radial direction). The total
porosity of cortical bone was calculated as the total pore volume divided by the total
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cortical bone volume, the axial porosity was calculated as the axial porous volume
divided by total cortical bone volume, and the radial porosity was calculated as the radial
porous volume divided by total cortical bone volume. Segmented pore volumes were then
imported into MicroView for anisotropy analysis that utilized a mean intercept length
approach in which intersections of a test grid composed of lines separated by 3 pixels
were passed through each volume at 200 different angles to generate a fabric ellipsoid
whose long axis was aligned in the direction of the most prominent structural orientation.
Lastly, Euler's number for both the axial and radial components of the segmented porous
content of each sample was calculated and divided by total bone ("filled") volume to
determine connectivity density (mm-3).
Repeat measures for Analysis of variance (ANOVA) (Friedman Repeated Measures
of ANOVA) were used for statistical analysis (SigmaStat software v3.5). Quantitative
results are reported as the mean ± standard deviation. Unless stated otherwise, statistical
significance was set at a p value of less than 0.05.
4. 3 Results
4.3.1 Structure and Porosity of cortical bone
The structural properties of cortical bone wafers cut from adult canine tibial
diaphyses were assessed after removing bone marrow and periosteum soft tissues. Gross
observations of each bone wafer showed that the endosteal surface contained large ridges
and valleys as compared to the cut surface (Fig 4.4A and B, ES versus CS panels).
Environmental scanning electron microscopy images of each bone wafer showed that the
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natural endosteal surface (ES) exhibited numerous large pores (50 – 100 µm width) and
intermediate-sized pores (10 - 50

µm width) (Fig 4.4C).

Similar imaging of the

opposing cut surface (CS) of these bone wafers revealed fewer intermediate-sized pores

Figure 4-4 Images of cortical bone wafers prior to permeability measurement.
Panel A shows a representative gross view of a natural endosteal surface (ES) from a
bone wafer. Panel B shows a representative gross view of the opposing cut surface
(CS) from the bone wafer shown in panel A. Panel C shows an environmental
scanning electron microscope image of the natural endosteal surface from a bone
wafer. Panel D shows an environmental scanning electron microscope image of the
opposing cut surface from the same bone wafer shown in panel C; the roughly parallel
ridges apparent in the image are generated by the rotary cutting blade. Inset image in
panel D is a higher magnification view revealing the presence of small pores along the
cut surface of a bone wafer. Arrow points to the pores.
and numerous small pores (1 – 5 µm width), but no large pores (Fig. 4.4D and inset).
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Figure 4-5 Porosity and connectivity measurement of cortical bone wafers. Panel
A shows a representative 3D micro-CT scanning image at 3 µm resolution. Panel B
shows a representative inverted 3D micro-CT image in the radial direction. Panel C
shows a representative inverted 3D micro-CT image in the axial direction. Panel D
shows the total, radial and axial porosity of cortical bone. Panel E shows the radial
and axial connectivity of the porous compartment in cortical bone. Shown are box and
whisker plots exhibiting median (line within the box) and percentiles of the data. The
ends of the boxes define 25th and 75th percentiles, and the two bars outside the box
define 10th and 90th percentiles. Scale bars in panel A-C are 200 µm.
Presence of pores on both sides of the bone wafers suggested that some of these pores
may interconnect across the wafer thickness and provide channels for fluid flow.
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Three dimensional, micro-CT imaging was used to assess the validity of this
suggestion (Fig. 4.5). Micro-CT imaging (at 3 µm resolution) showed that the pores on
both sides of the cortical bone wafers were interconnected across the wafer thickness
both radially and axially (Fig. 4.5 B, C). Our calculations showed that the total porosity
of adult canine cortical bone wafers was 2.95 ± 0.91%, the radial porosity was 0.60 ±
0.17%, and axial porosity was 2.36 ± 0.71% (Fig. 4.5D).

Connectivity density

calculations revealed a value for radial connectivity of 175 ± 87mm-3 and axial
connectivity of 438 ± 204 mm3

(Fig. 4.5 E).

4.3.2

Radial

hydraulic

permeability of cortical bone
1.

The

Permeability

of

unprocessed cortical bone
Figure 4.6 shows that
the

radial

hydraulic

permeability of fresh cortical
bone wafers (1.5-mm thick)
was below the detection limit
of our customized system (4.0
x

10

-17

2

m ).

Figure 4-6 The permeability of cortical bone.
We

set
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unprocessed bone at this limit value because prior evidence by Li et al [46] indicated the
radial hydraulic permeability of adult canine cortical bone to be 5 x 10-17 m2.
2. Contribution of lipids to the permeability of cortical bone
Figure 4.6 shows that after acetonemethanol

(AM)

treatment,

the

permeability of bone wafers (1.5-mm
thick) increased to 1.2 x 10-15 ± 1.1 x 1015

m2. Thus, the increase in permeability

after AM treatment suggests that lipids in
the porous compartment of cortical bone
restricted

its

radial

hydraulic

permeability.
3. Contribution of collagen to the
permeability of cortical bone
After AM treatment, cortical bone
wafers were then digested with high
purity bacterial collagenase. Comparing
the permeability of cortical bone before
and after collagenase treatment with one
way ANOVA, the differences in the
mean value between these two groups

Figure 4-7 Lipids extracted from cortical
bone wafers by acetone-methanol (AM)
treatment. Panel A shows the absolute
amount of lipids recovered from the AM
solutions normalized to the wet weight of
each bone wafer. Panel B shows the
percentage composition of extracted lipids
recovered from the AM solutions. FFA: Free
fatty acids. PL: Polar lipids. TAG:
Triacylglycerols. Chol: cholesterol
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were greater than would be expected by chance (P < 0.001). Specifically Figure 4.6
shows that the permeability of 1.5-mm thick specimens significantly increased to 5.6 x
10-15 ± 8.3 x 10-15 m2 after collagenase digestion, which suggested that the densely
packed collagen matrix also restricted radial hydraulic permeability of cortical bone.
After collagenase treatment, cortical bone wafers were then digested with bacterial
dispase solution. Comparing the permeability of cortical bone before and after dispase
treatment with one way ANOVA, the difference in the mean value between these two
groups was not great enough to reject the possibility that the difference might be due to
random sampling ( p = 0.197). Specifically, there was no significance between the
permeability of bone wafers before and after dispase treatment, which suggested that bulk
removal of the organic matrix is not necessary to elevate its permeability.
4. Contribution of mineral to the permeability of cortical bone
The contribution of the non-porous compartment to the permeability of cortical
bone can only be accessed by removing its calcium mineral salts, here by using EDTA
treatment. After dispase treatment, cortical bone wafers were then treated with EDTA
solution. Comparing the permeability of cortical bone before and after EDTA
decalcification with one way ANOVA, the differences in the mean value between these
two groups were greater than would be expected by chance (P < 0.001). Specifically, Fig
4.6 shows that after EDTA decalcification, the radial hydraulic permeability of the bone
wafers was increased to 2.9 x 10-14 ± 4.1 x 10-14 m2. No surprisingly, this suggested that
the mineral content of bone restricts its permeability.
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5. Lipids in the porous compartment of cortical bone
To confirm that lipids were removed from these cortical bone wafers by AM
treatment, the organic solvent phase of the recovered AM extracts was evaporated and the
dried waxy residue was submitted to gas chromatography separation and mass
spectrometry detection of free fatty acids, phospholipids and triacylglycerols and
cholesterol was measured with a colorimetric method [67]. In total, these four types of
lipids comprised ~76 % of the residue’s dry
weight and accounted for ~9 mg/g wet
weight of cortical bone. Triacylglycerols
comprised the largest class of lipids (60%),
followed by cholesterol (11%), free fatty
acids (~4%) and phospholipids (~0.5%).
6. Collagen in the porous compartment of
cortical bone
To confirm digestion of fibrillar collagen
from these bone wafers, the amounts of
hydroxyl-proline
collagenase

released

digestion

into

solution

the
were

measured (Fig 4.8, CS) and found to be 63 ±
37

µg

hydroxyl-proline/g

wet

bone.

Figure 4-8 Amounts of hydroxyl-proline
released from cortical bone wafers by
collagenase digestion. CS represents the
amount of hydroxyl-proline released into
solution from the porous compartment of
bone wafers by bacterial collagenase
digestion. Bone, represents the amount of
hydroxyl-proline released into solution
from the collagenous matrix within the
non-porous compartment after complete
decalcification of bone wafers using
EDTA.

Additional digestion of these bone wafers after collagenase with dispase released an
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additional 90 ± 110 µg hydroxyl-proline/g wet bone. This observation suggested that
collagenase digestion did not remove all the fibrillar collagen content from the porous
compartment of these bone wafers. After EDTA treatment, the insoluble matrix from the
decalcified bone wafers was totally hydrolyzed to measure its total amount of hydroxylproline. The hydroxyl-proline content in the insoluble matrix of decalcified bone wafers
was 3100 ± 1800 µg/g wet bone (Fig. 4.8, bone). Using the values of hydroxyl-proline
released by collagenase and dispase digestions mentioned above, the relative proportion
of the porous to non-porous collagen content was calculated to be 4.9% (= [63 +
90]/3100 x 100%). This relative proportion of hydroxyl-proline content is close to the
average porosity value (~3%) calculated from micro-CT imaging in Fig 4.5.
4.4 Discussion
In living bone tissue, interstitial fluids flow through a porous compartment containing
vascular channels referred to as Haversian and Volkmann’s canals [9, 88]. Fluid flow is
important for the transport of nutrients, growth factors, and waste products inside bone.
The permeability of cortical bone is the measurement of the ease of the fluid flow
through the cortical bone [69]. The objective in this chapter was to identify some of the
components in the porous compartment of cortical bone that regulate its radial hydraulic
permeability. Two hypotheses were tested in this chapter: (1) the presence of
hydrophobic molecules within the porous compartment of cortical bone restricts its
hydraulic permeability; and (2) the presence of a densely packed pericellular matrix
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(containing collagen fibers) will reduce the hydraulic permeability within the porous
compartment of cortical bone.
Until now, few studies have experimentally measured the permeability of cortical
bone. The earliest work was done by Johnson et al. [39] and they determined that the
radial permeability of cortical bone containing large vascular channels was 2.5 x 10-14 m2.
Li et al. [46] measured the radial permeability of fresh cortical bone devoid of large
vascular channels and after removing 0.5-1.0 mm of bone from the periosteal surface.
Their results revealed that the average radial permeability of cortical bone from adult
canine tibiae was 5 x 10-17 m2. Beno et al. [7] estimated the permeability within cortical
bone based on finite elemental analysis using microstructural measurements strictly of
the lacuna-canalicular system. They predicted that the permeability of cortical bone at the
lacuna-canalicular level was in the range of 10-18~10-20 m2. They concluded that the
permeability of actual cortical bone tissue should be higher than this value given that
bone tissue contains both a lacuna-canalicular system and larger inter-connecting
channels. We could not measure the permeability of unprocessed bone wafers (1.5 mm)
since the detection limit of our device is 4 x 10-17 m2. However, based on the Darcy’s law,
if we decreased the thickness of the bone wafers, we can lower the detection limit of the
device. Moreover, the pressure limit of the bone holder is 150 PSI, increasing the
pressure limit of the bone holder can also lower the detect limit of the device. Still, we
were able to measure the permeability of bone wafers with 200 µm thickness, and found
its permeability is in the range of 4.0 x 10-16 m2 to 1.0 x 10-17 m2, consistent with these
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previous determinations. The limitation here is that there may be difference between the
permeability of the thinner and thicker bone wafers since the pore space of cortical bone
has a hierarchical structure.
The porous compartment of bone is mainly composed of type I collagen fibers, noncollagenous proteins, lipids and cells [9]. The contributions exerted on bone’s hydraulic
permeability by these various organic components within the porous compartment of
cortical bone have not been determined until now. This knowledge should help to better
understand the regulation of fluid flow inside bone tissue. In turns, this may help in vitro
bone tissue engineering approaches to improve the design of new bone scaffolds to better
mimic in vivo properties.
Our finding that removing lipids from the porous compartment of cortical bone
increased its radial hydraulic permeability indicates that the presence of lipids in the
porous compartment of cortical bone reduces its permeability and suggests that the
presence of such lipids is a factor restricting fluid flow in cortical bone. Our lipid
composition results are consistent with those reported by Dirksen and Marinetti [19] and
Leach [45] who measured the lipid contents of human and ox cortical bone and found
high levels of triacylglycerols and low levels of phospholipids.
The lipid composition results suggest that osteocyte cell membranes and any vesicles
that bleb off from these membranes are not likely to be the major source of lipids located
in the non-porous compartment of bone since they both have a high content of
phospholipids[9]. Instead, triacylglycerols comprise the major source of lipids in this
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bone compartment, and this observation raises an intriguing hypothesis for the source of
this hydrophobic material. Triacylglycerols are produced inside most vertebrate cells
including those in the osteogenic lineage and stored within lipid droplets [82]. Takahashi
[82]et al. have shown that osteogenic cells can secrete lipid droplets into their
extracellular matrix.

Thus, the source of these triacylgycerols extracted from fresh

cortical bone might originate from secretion by its resident bone cell populations
(osteoblasts lining Haversian and Volkman canals and osteocytes embedded within the
lacuna-canalicular system). It is unclear at present what would regulate this secretion
process and why such hydrophobic materials are deposited within the porous
compartment of cortical bone tissue.
In addition to lipids reducing the radial permeability of cortical bone, we determined
that the densely packed pericellular matrix [67] within the porous compartment of
cortical bone also reduced its permeability. Removal and/or loosening of the collagenrich matrix in the porous compartment of cortical bone with collagenase digestion
substantially increased its permeability. This indicates that the pericellular matrix in the
porous compartment of cortical restricts fluid flow and represents another factor
regulating its permeability.
There were some limitations that should be addressed in future. Studies includes: (1)
the hydraulic permeability of cortical bone needs to be measured. To do this there are two
methods can be used: (a) with current device, the bone wafers can be cut into several
pieces of thinner wafers with same thickness and the hydraulic permeability of these
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wafers will be measured at same conditions; then the hydraulic permeability of bone
wafers will be average of all these measurements; (b) a new device with lower detection
limit needs to be made. Right now the detect limit of the present device results from the
pressure limit of the holder made of PVC. Therefore, the bone holder made from stainless
steel with same design as proposed in this chapter will increase the pressure limit of the
bone holder thereby lower the detection limit. Compare to method (a) the advantage of
this method is that the hydraulic permeability can be measured directly and the
disadvantage is that some cost will be applied on the new device. (2) Hydraulic
permeability of the cortical bone from periosteum side and the contribution of bone
components to its permeability need to be studied to understand the mechanism of the
nutrient and waste transport underneath periosteum layer, which is critical important for
bone formation in vivo. To do this, a new device with much lower detect limit needed. (3)
Changes in ultrastructure of the remaining pericellular matrix after removing lipids and /
or collagen may have effect on the changes on the permeability. To determine whether
there is the change of ultrastructure, transmission electron microscopy (TEM) images of
the wafers after collagenase and or acetone methonal treatment need to be compared with
that of the wafers before treatments.
Altogether, our results from this study showed that the presence of lipids and
collagen-rich pericellular matrix within the porous compartment of canine cortical bone
reduced permeability in a radial direction and thereby restricted fluid flow through this
bone tissue compartment. The findings in this study may have bearing on investigations
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attempting to promote bone formation in vitro via tissue engineering approaches.
Perhaps the presence and distribution of lipids and densely packed collagen matrix
applied to appropriate scaffolds may help promote osteogenic differentiation of
progenitor cells and produce a more bone-like tissue construct in bone bioreactor designs.
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CHAPTER V
EXPERIMENTAL MEASUREMENT AND MATHEMATICAL MODEL OF
GLUCOSE DIFFUSION IN CORTICAL BONE SCAFFOLD

5.1 Introduction
Glucose supply always needs to be considered in bone tissue engineering since it is
essential to maintain cell viability [66]. Several studies have attempted to improve
glucose supply, such as using rotating flasks instead of conventional immobile flasks [79].
In our proposed bone tissue engineering system, the 3D scaffold will consist of a cortical
bone under layment and a type I collagen- fibronectin hydrogel interface to promote bone
cell attachment this scaffold. In this 3D scaffold design, glucose will be supplied from
both top and bottom of the 3D scaffold. Under static culture conditions, glucose transport
is only mediated by diffusion. Over extended culture time under these conditions, nutrient
supply may become limited for the metabolism of bone cells. To determine when glucose
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becomes limited in our system, the glucose concentration profile will be calculated by a
mathematical model. Mathematically, to calculate the glucose concentration profile, the
diffusion coefficient of glucose needs to be known. Up to now, few studies have
measured a glucose diffusion coefficient in cortical bone [35, 43]. Jackson et al. reported
that the glucose diffusivity in bovine annulus fibrous was 1.38 x 10-10 m2 /s [35]. Lang et
al showed that the glucose diffusivity in bone was in the magnitude of 3 x 10-13 m2/s [43].
Therefore in this chapter: (1) the diffusion coefficient of glucose in cortical bone in a
radial direction was measured with diffusion cell; and (2) a mathematical model was
established to generate the glucose diffusion profile in our system.
5.2 Experimental measurement of glucose diffusion in cortical bone
5.2.1 Materials and methods
1. Bone wafer preparation:
All bone tissues were obtained from animals that had been sacrificed in the course of
IACUC approved research investigations conducted elsewhere at this institution. Middiaphyseal portions of tibia were harvested from outbred adult canines (~25-30 kg body
weight). Periosteal tissue layers, including most of the basal cambium cell layer, were
stripped off the bone by dissection. Bone marrow was flushed out of the bone with
phosphate buffer saline (PBS) (Cellgro). These tibial diaphyses were then stored in PBS
with 0.05% sodium azide (Sigma) at 4° C and used within a 2 week period from
collection. Cortical bone wafers from the endosteal side of tibial diaphyses with
dimensions of 15 mm length, 15 mm width, and 200 µm thick were cut with an EXTEC
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® Labcut 1010 Low Speed Diamond Saw (EXTEC Corp). Six bone wafers were
submitted for glucose diffusion measurements. These wafers were selected from the same
tibial for which permeability values were determined.
2. Diffusion measurements with a diffusion cell system
Solute diffusion coefficients can be measured using a diffusion cell system as shown
in Figure 5-1 (Crown Glass, Somerville, NJ). A schematic of the diffusion cell system is
shown in Fig 5-2. The cell consists of two well- stirred compartments that contain known
volumes of a solute of interest (here glucose), separated by a thin membrane (here a 200
µm thin cortical bone wafer). Initially, each compartment is filled with differing solute
concentrations; typically a zero concentration on the receiver side and some specific
initial concentration on the donor side. In our experiments we chose a glucose
concentration of 2 mg/mL which is in the high physiological range. The flux of solute
(glucose) across the membrane (bone wafer) can be determined by the measurement of
the solute concentration in both donor and receiver sides over increasing time.
Experiments ran for 10 days each. The concentration of glucose was determined using
glucose assay kit based on hexokinase activity (Sigma). The glucose detection limit is
50µg / mL with this method.
3. Calculation of diffusion coefficients
We assume that these experiments are in pseudo-steady state (volume change can be
omitted in both donor and receiver sides). The solute concentrations in the donor and
receiver sides were assigned as CD (mg/mL) and CR (mg/mL) respectively, the volumes
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of solution in donor and receiver sides as VD (mL) and VR (mL), the fluid transport area
as A (mm2), and the flux rate of glucose as J. Therefore, the mass transfer equation (1) for
the donor side is:

VD

dC D
= − AJ
dt

(1)

The mass transfer equation (2) for the receiver side is:

VR

dC R
= AJ
dt

(2)

According to Fick’s law, the flux rate is:
J=

D
(CD − CR ) (3)
L

Here, D is the diffusion coefficient of the solute and L is the thickness of the cortical
bone. Since the volumes in the donor and receiver sides are equal, then we can
set: VD = VR = V .
Solving for D (the diffusion coefficient) using these three equations (1) ~ (3), we
generate the following equation (4):

D=−

C − CR
LV
( Ln D
) (4)
CD0 − C R0
2 At

Therefore, upon measuring the concentrations of glucose in both the donor and
receiver sides at different time points, we can calculate the slope between time t and

Ln

CD − CR
, and then input the thickness of cortical bone (L), the area of fluid
C D0 − C R0
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Figure 5-1 Picture of diffusion cell system

Figure 5-2 Schematic of diffusion cell system
74

transport

area (A) and the volume of solution in donor and receiver side (V) therefore we can solve
for the diffusion coefficient (D).

Figure 5-3 Glucose concentration profile in both donor and receiver
id
5.2.2 Results
Figure 5-3 shows the glucose concentration profiles in both donor and receiver sides.
It showed that there is no change of glucose concentration in either side, suggesting that
the diffusion coefficient of glucose in cortical bone is very low and can not be measured
using the current diffusion cell system.
5.2.3 Discussion and conclusions
1. Limitation of the diffusion cell system:
In our system, the thickness of the cortical bone wafer is 200 µm, the fluid transport
area is a 7 mm diameter circle, the original glucose concentration in the donor side is 2
mg/mL, and the lowest concentration of glucose that can be detected in the receiver side
with our assay is 50 µg/mL. Given that each experiment ran for 10 days, we can input all
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these parameters in equation (4), and then back-calculate the lowest diffusion coefficient
that could be detected by this device (3.9 x 10-8 cm2 /s). Based on these calculations, we
conclude that the diffusion coefficient of glucose in cortical bone must be less than the
detect limit by this device. For future reference, in order to obtain an accurate measure of
the diffusion coefficient of glucose in cortical bone, a more sensitive assay method (such
as radio-labelled glucose), a thinner bone piece and / or extended experiment time can be
applied in new experiments.
2. Diffusion coefficient of glucose in cortical bone calculated from porosity and
tortuosity
Diffusion coefficients of solutes in porous materials are influenced by its porosity
and tortuosity [2, 73]. Several studies have been done to correlate the diffusion
coefficient of solutes in porous materials with respect to material porosity and tortuosity
[2, 73]. Since we were not able to accurately measure the diffusion coefficient of glucose
in adult cortical bone, we can calculate the diffusion coefficient of glucose in adult
cortical bone using an already established relationship between the diffusion coefficient
of a solute in a porous material and its porosity (ε) and tortuosity (τ) based on porosity
measurement of cortical bone (Chapter 4, 0.6% porosity in radial direction). Baron [2] et
al. reported the relationship between the effective diffusion coefficient in a porous glass
matrix and its porosity and toruosity as Equation (5):
Deff = D

ε
(5)
τ
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Here Deff is the diffusion coefficient in a porous glass matrix, D is the diffusion
coefficient in collagen, ε is porosity, and τ is tortuosity. Since cortical bone is composed
of disc-shaped mineral crystals and the packed pattern of the porous glass approximates
that of bone, we can apply this equation to calculate the diffusion coefficient of glucose
in cortical bone from its (1) porosity (ε), (2) tortuosity (τ), and (3) the diffusion
coefficient of glucose in a collagen matrix (D).
Since the mineral is disc-shaped in cortical bone, we can calculate its tortuosity from
its porosity based on equation

τ 2 = 1 − Ln(ε ) [73]

ε = 0.006 (Data from Chapter 4, the axial porosity of cortical bone 0.6% ) then τ = 2.47 .
The diffusion coefficient of glucose in collagen gel (D) is 1.3 x 10-6 cm2 /s [96]. Input all
parameters into equation 5, we calculate the diffusion coefficient of glucose in cortical
bone (Deff) to be 3.15 x 10-9 cm2/s. This value is consistent with the low end estimates of
glucose diffusion in cortical bone. It also explains why we were unable to accurately
measure the diffusion coefficient of glucose in our current diffusion cell system.
Therefore, we conclude that the glucose diffusion coefficient in cortical bone less is
than 3.9 x 10-8 cm2/s and maybe around 3.15 x 10-9 cm2/s.
5.3 Mathematical model of predicting a nutrient concentration profile in a 3D
scaffold made of cortical bone and a type I collagen-fibronectin hydrogel
5.3.1 Model establishment
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A concentration profile for small molecular weight nutrients inside a 3D scaffold
used for cortical bone tissue engineering can be calculated using a mass balance analysis.
This 3D scaffold includes bone cells on top of a type I collagen hydrogel layer
(mimicking an osteoid layer) and a porous cortical bone layer underneath the collagen
layer that has had its cellular contents removed by NaOH treatment. Assumptions were
made to calculate this concentration profile: (1) the diffusion process is at steady state, (2)
a nutrient is transported only by molecular diffusion and not by convection, (3) nutrient
consumption occurs only within the collagen gel layer and is consumed uniformly, and (4)
non-metabolic consumption of a nutrient is negligible within the 3D scaffold because the
nutrient content is well above the saturable limit for non-specific adsorption in the 3D
scaffold. This concentration profile represents the relationship between the distance from
the top surface of the collagen gel and the nutrient concentration at that site. The
following variables are defined: (1) the distance from the top surface of the collagen gel
is y, (2) the thickness of collagen gel is Lc, (3) the thickness of cortical bone is LB, (4) the
starting concentration of the nutrient in the medium is C0 and represents the concentration
at both the top surface of the collagen gel and the bottom surface of the cortical bone, (5)
the metabolic consumption rate in the collagen gel is rmax, and (6) the diffusion
coefficients of the nutrient in collagen gel and cortical bone layers are Dc and DB
respectively. A schematic of the concentration profile is shown in Figure 5.4.
The mass balance equation (6) in the collagen gel layer can be expressed as:
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d 2Cc
Dc
= rmax (6)
dy 2
The

mass

equation

(7)

balance
in

the

cortical bone layer can
be expressed as:
d 2C B
DB
= 0 (7)
dy 2
The concentration of

Figure 5-4 The schematic of concentration profile of
the nutrient in 3D scaffold

nutrient at both the top surface of the collagen gel and bottom surface of the cortical bone
is C0. We can set boundary equations (8) and (9) as:
y = 0, C c = C 0 (8)
y = Lc + LB , C B = C0 (9)
At the boundary between the collagen gel and cortical bone, since they refer to the
same interfacial surface, their concentrations and transport rates are the same. We can set
boundary equations (10) and (11) respectively:
y = Lc , C c = C B (10)
y = Lc , Dc

dC c
dC B
(11)
= DB
dy
dy

Intergrating equations (6) and (7) and applying the boundary equations (8)-(11) into
these two equations, the nutrient concentration profile equations for both the collagen gel
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layer and the cortical bone layer can be derived to yield equation (12) as the profile in the
collagen layer and equation (13) as the profile in the cortical bone layer.
2

r
rmax D B Lc
r
C c = max y 2 + (
− max Lc ) y + C 0 (12)
2 Dc
2 Dc ( LB + D B Lc ) Dc
2

CB =

2

rmax Lc
r L ( L + LB )
y − max c c
+ C 0 (13)
2 Dc ( LB + D B Lc )
2 Dc ( D B LC + LB )

5.3.2 Discussion
1. Application of this model
Based on our assumption, this model can only be applied to predict the nutrient
concentration when the transport process is (1) at steady state, (2) only through molecular
diffusion, (3) uniform consumption in the upper layer and (4) no consumption in the
lower layer. Therefore, it can be used to predict the concentration of any nutrient or waste
product molecules in the scaffold (composed of 2 layers) in static culture. It can not be
used to predict a nutrient concentration in cortical bone in vivo since there is nutrient
consumption in cortical bone. To be able to predict a nutrient concentration in vivo, a
consumption factor needs to be added in equation (7) and diffusion coefficient (D) needs
to be modified to incorporate any convection influence.
2. Glucose concentration profiles in a 3-D scaffold design for bone tissue engineering in
vitro
Using the above equations, we can calculate glucose concentration profiles in a 3-D
scaffold made of a cortical bone wafer and a type I collagen hydrogel (Fig 5.4). Values
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for the following variables were obtained from the literature: (1) our analysis suggested
that the diffusion coefficient of glucose in cortical bone (DB) is in the range of 3.9 x 10-8
~ 3.15 x 10-9 cm2/s, and here we assume a value within this range DB= 1x 10-8 cm2/s; (2)
the diffusion coefficient of glucose in a collagen gel (Dc) is 1.3 x 10-6 cm2/s, and (3) the
specific glucose consumption rate of 1 x 10

6

osteoblasts in bone is assumed to be 320

nmol/h [97]. In our system, the thickness of the cortical bone scaffold would be 300 µm
thick and the cells plus artificial osteoid layer yield a combined 30 µm thickness. We
assume the maxium cell density in collagen gel layer is 5000 cells /mm2 (based on the
average cell density in the cultures with collagen-fibronectin hydrogel, Chaper 6, Figure
6-14), making the consumption rate of glucose in the collagen gel layer rmax = 320 nmol/h
x 5000 cells/mm2 / (1 x 106 cells) [70]. We set the starting glucose concentration C0 as 1
mg/mL as this is the physiological concentration of glucose in the growth medium.
Putting all these parameters into equations (12) and (13), we can calculate the glucose
concentration profile for the collagen gel and cortical bone layers respectively (Figure 55). These profiles can be expressed as equations (14) and (15) respectively.
Equations:
y = 0.0004 x 2 − 0.0239 x + 1 (14)
y = 1.1963 x − 0.6052 (15)
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Figure 5-5 Glucose concentration profile in the culture on the scaffold. A: in the
collagen gel layer; B: in scaffold layer
These profiles show that the glucose concentration in the collagen gel layer decreased
from 1 mg/mL to 0.64 mg/mL from its top to bottom surface. The glucose concentration
in the cortical bone layer decreased from 1 mg/mL to 0.64 mg/mL from its bottom to top
surface. This suggests that there is no limitation of glucose supply for bone cells to grow
up to 30 µm thick on this type of cortical bone scaffold.
3. The thickness of a bone cell layer growing on a 300 µm cortical bone scaffold without
nutrient limitation.
When the glucose concentration on the bottom surface of the collagen gel becomes 0,
the glucose supply would become limiting for cell survival, proliferation and/ or
differentiation. During culture it is anticipated that new bone tissue would be deposited
beneath the cell layer and in the collagen matrix over incubation time. If we set the
concentration on the bottom of the collagen gel as 0, we can re-calculate the accumulated
thickness of new matrix beneath the cell layer by equation (12) and (13) and it is 50 µm
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on the scaffold. These calculations suggest that the highest amount of new bone tissue
that can be deposited in this system is 50 µm. To grow more tissue in this static system,
we would need to improve nutrient (glucose) transport, which could be accomplished by
applying dynamic mechanical loads to introduce convection to promote nutrient transport.
4. Glucose transport in cortical bone in vivo
Glucose transport is considered important in cortical bone in order to maintain the
viability of its constituent bone cells. Transport can be accomplished via diffusion,
convection force and carrier diffusion. Here, we empirically measured the diffusion of
glucose in cortical bone with a diffusion chamber. Our results showed that the diffusion
coefficient of glucose in cortical bone was very low. After 10 days, few amount of
glucose diffused through a 200 µm bone wafer. Given that osteocytes remain viable in
bone tissue in vivo then it is more likely the transport of glucose in cortical bone is
achieved by convection forces that move fluids (caused by dynamic mechanical load and
blood pressure). Alternatively, perhaps there is another metabolic nutrient source to meet
the needs of bone cells’ consumption. For example, extracellular lipids, may be
internalized and degraded to carbon units that might meet the metabolic needs of
osteocytes.
There were some limitations that should be addressed in future. Studies includes: (1)
the glucose diffusion coefficient in cortical bone could not be measured in current
diffusion cell system. The detect limit of current system results from the method used to
measure the glucose concentration. Therefore in future a more sensitive detection method
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needs to apply this system, such as using radiolabel chemicals. (2) Oxygen transport is
another important issue to be considered in bioreactor system. Diffusion coefficient of
oxygen needs to be studied to generate the oxygen concentration profile with this model
system [66]. (2) Based on my lipids data from Chapter IV, there were considerable
amount of lipids in porous compartment of cortical bone. Therefore the diffusion
coefficient of hydrophobic molecules (such as prostaglandin [64]) in cortical bone needs
to be studied to better understand the nutrient transport inside the bone. (3) Fluid flow
caused by mechanical load increases the nutrient and waste product transport inside the
bone [18]. Therefore, the diffusion coefficient of glucose in cortical bone under
mechanical load needs to be studied to better understand the nutrient transport inside the
bone. (4) This mathematical model system can only be applied to the static system since
only molecular diffusion was considered for glucose transport in this system. Therefore,
in future convection factors needed to be included in the model system to predict the
glucose concentration profile in the system with mechanical load.
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CHAPTER VI
BASOLATERAL MINERAL DEPOSITION BY VARIOUS OSTEOBLAST
SOURCES CULTURED ON 3D COLLAGEN FIBRONECTIN HYDROGEL
SCAFFOLDS

6. 1 Introduction
Cell source and scaffold material are two key components in bone tissue engineering
[39, 66]. Until now, sources of cells used in bone tissue engineering have included
mesenchymal stem cells derived from different tissues, such as bone marrow, periosteum,
human umbilical cord blood [5, 6, 13, 29, 30, 33, 39, 42, 50, 51, 76-79, 89], and mature
osteoblasts, such as primary cells from human trabecular bone obtained during iliac crest
biopsies [60]. Bone marrow is the highly cellular tissue found in the medullary cavity of
long bones (see Figure 2-1). Cells from bone marrow comprise a heterogeneous group of
phenotypes including hematopoietic stem cells, mesenchymal stem cells and endothelial
stem cells [9, 66]. Mesenchymal stem cells, a source of primary cells used in bone tissue
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engineering, can be separated from the other two stem cell populations by a colony
forming adhesion assay [66]. In vitro, studies have shown the osteogeneic potential of
bone marrow cells. For example, Barralet et al. cultured bone marrow cells on type I
collagen gels for 21-28 days and showed new osteoid-like tissue formation by these cells
[6]. Sikavitsas et al. cultured bone marrow cells in a flow perfusion bioreactor and
showed that such a fluid-flow bioreactor culture system minimized diffusion constraints
and provided mechanical stimulation to the bone marrow cells, leading to the
accumulation of a cancellous bone-like mineralized tissue [78].
Osteo-progenitor cells also reside within the periosteal cambium layer and can
develop into osteoblasts, which are responsible for increasing the width of a long bone
and the overall size of axial and craniofacial bone types [48]. These osteo-progenitor cells
can be isolated, which provides another source of primary osteoblastic cells for bone
tissue engineering [48]. Several studies have reported on the osteogenic properties of
periosteal cells. Wiesmann et al. cultured periosteal derived osteoblasts on Petri dishes as
well as within 3D collagen constructs. They showed that these cells can form ‘bone like’
mineral deposits in both 2- and 3-D environments and formed an extracellular matrix
containing osteocalcin, SPARC (osteonectin), and newly synthesized collagen type I in
both environments [89]. Koshihara et al. showed that periosteum cells are osteoblastic
cells that could differentiate into osteocytes and deposited calcified mineral in response to
1, 25 dihydroxyvitamin D3 [48].
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Figure 6-1 The morphology of cells in the periosteum. Done in Midura lab

In vivo periosteum, (Figure 6-1) is composed of 6~7 cell layers; three different cell types
are located in periosteum tissue: osteo-progenitor cells, pre-osteoblasts and osteoblasts.
Pre-osteocytes are located within the osteoid layer-- the densely packed type I collagen
rich organic matrix secreted by mature surface osteoblasts that eventually becomes
mineralized and forms bone tissue [9]. All these cells are responsible for increasing the
width of a long bone’s diaphysis and the overall thickness of bone types [9]. The
morphology of these cells is different: from spindle shaped osteo-progenitors with a
nuclear length/ width aspect ratio of 8- 9 at top cell layer (apical) to round/ cuboidal
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shaped osteoblasts with an aspect ratio of 1- 2 at the bottom cell layer (basal). Moreover
the space between nuclei in each layer from top to bottom is different, suggesting that
different cell layers may contain different densities of cells. All of these observations
indicate a polar distribution of cells and extracellular matrix along the bone formation
front, whereby apical cells are more flattened than basal cells, and extracellular matrix
accumulates beneath the basal cells. This kind of cell and matrix distribution may be
important for continual bone formationin vivo.
To mimic the periosteum tissue structure in vitro, osteo-progenitors derived from
bone marrow or periosteum could be used to form bone cell layers on a 3D collagenfibronectin hydrogel (artificial osteoid layer) intended to represent a bioartificial osteoid
layer. In this system we hypothesized that: (1) extracellular matrix protein and mineral
deposition in bone marrow and periosteum 3D collagen fibronectin hydrogel cell cultures
will be higher comparing to on conventional 2D tissue plastic; (2) cell density,
extracellular matrix protein and mineral deposition in bone marrow and periosteum 3D
collagen fibronectin hydrogel cell cultures will exhibit a basal lateral deposition pattern
while not on 2D conventional tissue plastic; (3) cell nuclear morphology at different
stages of osteogenesis would exhibit different aspect ratio; (4)osteo-progenitors derived
from bone marrow and periosteum cells exhibit equivalent osteogenic capacity.
In order to test these hypotheses, bone marrow and periosteum cells were isolated
from tibial diaphyses of juvenile rats because they are two conventional normal
osteoblast models. A bio-artificial osteoid matrix was constructed using matrix type I
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collagen gelled into 3D hydrogels coated with fibronectin because the components of
osteoid layer is type I collagen (mainly) and some other extracellular protein (such as
fibronectin); and studies showed that fibronectin and collagen scaffold promoted
osteogenesis of osteoblasts in vitro. The experimental design used in this study employed
a direct comparison of the same bone cell type cultured on the 3D bio- artificial osteoid
matrix versus on conventional 2D tissue culture plastic surfaces. 3-4 weeks (25 days)
culture period was selected based on prior knowledge that this is first time period to
reliably assess mineral content in vitro [6, 30, 48]. The outcomes included the amount
and distribution of cell nuclei density, extracellular matrix (bone sialoprotein (BSP [9,
26]) and sereted protein acid rich with cysteines (SPARC [9, 38])) and calcium mineral
[9, 68] deposited in the cultures. SPARC and BSP were selected as indicators of
ostoegenesis because they are both bone matrix molecules that exhibit calcium binding
properties and are deposited by osteoblast cells at different stage of osteogenic
differentiation. The expression of SPARC occurs when osteoblasts stop proliferating and
begin terminal differentiation. It is considered to be an early to intermediate marker of
osteoblast differentiation [9, 38]. The expression of BSP occurs at a later stage of
osteogenic differentiation coinciding with the ability to deposit calcium mineral [9, 26].
Ultimately, the unique attribute of osteoblast activity is the ability to deposit
hydroxyapaptite crystals (calcium mineral) [9, 68] in a collagenous tissue matrix.
Specifically, osteo- progenitor cells derived from two different cell sources (bone
marrow and periosteum) were cultured on two culture modality (3D collagen-fibronectin
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hydrogels and 2D conventional tissue plastic) for 25 days respectively in two culture
conditions (growth medium and differentiation medium) (three cultures were done for
each group (n=3)) for a total of 8 groups. At 25 days, the cultures were cultures were
fixed and underwent standard paraffin histological processing. H&E staining was used to
provide gross observation of the culture. 4',6-diamidino-2-phenylindole (DAPI) staining
was used for nuclei morphology and nuclei number analysis. Immunohistochemistry
staining of BSP and SPARC was used for the analysis of BSP and SPARC deposition.
Alizarin red S staining was used for the analysis of calcium mineral deposition confirmed
by decalcification in serial sections. Three slides were stained for each staining. 25 ~30
images were taken for each slide for each staining and the image-Pro software was used
for quantification analysis. The amount (quantity) of extracellular matrix (BSP, SPARC)
and mineral deposited on the cultures was defined as the average positive stained area per
layer within each image. The distribution of extracellular matrix and mineral was defined
as the spreading of positive stained area in each layer within image.
6. 2 Methods and procedures
6. 2.1 Preparation of type I collagen Gel
A 2 mg/mL type I collagen solution was prepared from a stock of native rat tail type
I collagen solution (3.56 mg/mL, Gibco). 250 µL aliquot of the 2 mg/mL collagen
solution was placed into each well of 12-well plate sitting on ice. The plate was placed
into a 370 C incubator overnight to let the collagen gel solidify. A 2 µg/mL fibronectin
solution was prepared from a stock of fibronectin powder (1mg stock stored in - 20 0C,
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Sigma). A 200 µL aliquot of the 2 µg/mL fibronectin solution was placed onto each
collagen gel. The plate was incubated at 370 C for 2 hours to coat the collagen gel with
fibronectin because fibronectin has collagen binding domains. Each well was washed
with 500 µL of phosphate buffered saline solution (PBS) for 10 times to remove any
unbound fibronectin. An aliquot of 500 µL growth medium was put in each well and the
plate was incubated at 370 C for overnight to equilibrate the collagen-fibronectin gel with
culture medium. The collagen-fibronectin gel was ready for use in cell culture
experiments.
6.2.2 Cell culture
1. Isolation of periosteum and bone marrow cells from rat tibia
All of the animal procedures used in this study were reviewed and approved by the
Institutional Animal Care and Use Committee. The periosteum and bone tissue were
harvested according to a previously published protocol [48]. Briefly 12 Harlan-SpragueDawley male rats of one month age (40~ 45g body weight) were euthanized by
asphyxiation with CO2. A 7-mm-long segment from the middle diaphysis of each tibia
was obtained from the rats using aseptic techniques. Periosteal tissue layers, including
most of the basal cambium cell layer were stripped off the bone by dissection, and bone
marrow tissue was flushed out of the medullary cavity. Recovered periosteum tissues
were placed into a 50 mL tube containing 3 mL Dulbecco’s Modified Eagle’s Medium
(DMEM) (Sigma) solution supplemented with 0.6 Unit/mL Dispase (Gibco) and 100
Unit/mL bacterial Collagenase (Sigma). Cells were released from the periosteum matrix
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by incubation in this digestion solution at 370 C for 2 hours at which time all the tissue
matrix was completed dissolved. Cells were recovered from the digestion solution by
centrifugation at 100g for 5 min, and re-suspended in 2 mL growth medium (α-minimal
essential medium (MEM, Cellgro) supplemented with 10% FBS (Hyclone), 20 mM
HEPES (Cellgro), 20 µg/ml gentamycin (Sigma), and 0.25 µg/ml Amphoterin B (Sigma)).
This cell suspension solution was placed into a 35 mm culture dish and incubated at 37o C
in a 5% CO2 humidified incubator. After 48 hr incubation, the medium was replaced and
adherent cells were cultured for 5~6 more days to reach confluence with medium
exchanges every 2 days. At this time, periosteum cells were ready for culture experiments.
Bone marrow tissue was placed into a 100 mm dish containing 10 mL of growth
medium. Cells were released by repeated pipeting through 18 gage needles and
transferred into a 50 mL tube. Cells were recovered by centrifugation at 100g for 5 min
and re-suspended in 2 mL growth medium. This cell suspension solution was placed into
a 35 mm culture dish and incubated at 37o C in a 5% CO2 humidified incubator. After 48
hr of incubation, the medium was replaced and adherent cells were cultured for 5~6 more
days to reach confluence with medium exchanges every 2 days. At this time bone marrow
cells were ready for culture experiments.
2. Cell culture
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Figure

6-2
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culture
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histology.

For both cell types, cells were typsinized, counted and then seeded onto conventional
2D tissue culture plastic or 3D collagen-fibronectin hydrogels in a 12 well plate at an
initial density of 200 cells/mm2, a density at which cells became confluent in 4 days
(Figure 6-2). For the first four days of incubation, cells were cultured with 250 µL of
growth medium. At this time point, for each cell type and each culture modality (2D and
3D), cells were separated into two sub-groups. One sub-group was maintained in growth
medium (250 µL/ well) for another 21 days with media exchanges every other day. The
second sub-group was switched to an osteogenic differentiation medium (250 µL/ well)
for another 21 days with media exchanges every other day. Growth medium was α-MEM
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(Cellgro) supplemented with 10% FBS (Hyclone), 20 mM HEPES (Cellgro), 20 ug/ml
gentamycin (Sigma) and 0.25 µg/ml Amphoterin B (Sigma). Differentiation medium
consisted of growth medium supplemented with 50 µg/mL L-ascorbic acid 2-phosphate
(Sigma), 50 µg/mL L-ascorbic acid (Sigma) and 10 mM β-glycerophosphate (Sigma).
6. 2.3 Histological processing
1. Fixation and embedding
At the end of the 25 day culture period, cultures were fixed with 2%
paraformaldehyde in PBS at 40 C overnight. Intact tissues were peeled off from the
culture well, dehydrated with an increasing series of ethanol concentrations, and
embedded in paraffin maintaining an orientation, that yielded cross-sections of each
tissue in order to locate the top and bottom of each culture (Figure 6-2).
2. H & E staining
An overall histological assessment of each culture was determined by H&E staining. It
was done by the histology lab in Biomedical Engineering Department in Cleveland Clinic.
Specifically, three slices were de-paraffinized subsequently rinsed in running tap water
for 5 minutes to re-hydrate, then stained in Haematoxylin for 20-30 seconds, rinsed in the
running tap water until stain dissipated. To remove excess stain, the slices were treated
with 1% ammonium hydroxide for 10 seconds. This step was repeated to remove excess
bluing reagent. Then the slices were stained with Alcoholic Eosin for 1 minute and the
dehydration begin immediately by dipping sequentially for 10 seconds in each of Ethanol
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70%, 70%, 95%, 95%, Absolute Ethanol, Absolute Ethanol, Xylene, Xylene. Then the
slices were mounted in Cytoseal-XL, dried and stored in dust-free box until evaluated.
3. BSP and SPARC Staining
The presence of extracellular proteins BSP and SPARC in the cell and matrix layer of
each culture was determined with immunohistochemistry. Antibodies specific for BSP
(LF-100) and SPARC (Bon-1) were kindly provided by Dr. Larry Fisher [N. I. D. C. R,
NIH]. Three slides were deparaffinized and re-hydrated for 15 min with 50 mM TrisHCL buffer solution containing 150 mM sodium chloride (NaCl) (pH=7.5) (TBS), and
then incubated with 5% ovalbumin in TBS for 1 hr at room temperature to reduce nonspecific antibody binding. After ovalbumin blocking, the slides were incubated with
primary antibody solution in TBS with 0.1% ovalbumin (1:200 dilution) (LF100 or Bon1) for overnight at 4 oC. After primary antibody exposure, the slides were washed with
TBS three times for 10 min each time, and then incubated with Alexa-Fluor 488
(Invitrogen) anti-rabbit secondary antibody solution in TBS with 0.1% ovalbumin (1:200
dilution) at room temperature for 2 hours. Following secondary antibody treatment, the
slides were washed with TBS, 3 times for 10 min each time then stained with alizarin red.
The serial section for each test section was only incubated with secondary antibody and
stained under the same conditions as a control to determine secondary antibody nonspecific binding level (negative control).
4. Alizarin Red –S Staining
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Calcium mineral location in the culture sections was determined with alizarin red S
(ARS) staining. After BSP / SPARC staining, the slides were incubated with 0.4 mM
alizarin red S (Sigma) in milli-Q water solution (pH 4.52) for 10 min at room temperature
and then washed with TBS for 10 min. Slides were then ready for DAPI staining. A serial
section was decalcified with 10% trichloroacetic (Sigma, TCA) at 4 oC for 30 min and
stained with alizarin red S under same conditions. This section was set as alizarin red S
stain negative control image to determine the non-specific binding level of ARS to
collagen gel.
5. DAPI staining
Both ARS and SPARC or BSP stained sections were counter stained with DAPI for
cell nuclei identifying. The slides were incubated with 5 µg/mL DAPI in TBS solution
for 20 min at room temperature and washed with PBS solution 10 min each for 5 times.
Vectashield Mounting Medium (Vector Labs, H-1000) was added to each slide and a
glass coverslip was placed over each specimen and sealed with clear nail polish.
6.2.4 Image acquisition
Light or epi-fluorescent images of the samples were obtained using a Leica RXA2
upright wide –field microscope outfitted with a Spot-RT cooled-CCD camera. A total of
25-30 40 X field of view images (each 1520 x 1080 pixels) were imaged per slide. All
together, these images constituted ~ 70% of the total area of each tissue section thus
providing an accurate representation.
6.2.5 Image Analysis
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Nuclei morphology (aspect ratio), SPARC and BSP positive stained areas, as well as
alizarin red S (ARS) stained area were analyzed using commercially available image
processing software (ImagePro Plus Version 6.2, Media Cybernetics, MA); since this
method can enable us to generate both the amounts and distribution of cell nuclei density,
extracellular matrix and mineral deposition. Briefly DAPI and Alizarin red S (ARS)
images were uploaded into Image-Pro plus 6.2. Then a top boundary was set for both
DAPI and ARS images as follows: (1) select ARS image, (2) apply large-spectral filter to
equalize grayscales in all images, (3) apply a median filter to remove background noise,
(4) segment image to generate a binary mask, (5) apply same process on DAPI image, (6)
converge ARS and DAPI masks together, (7) fill in any discontinuous area with a
morphological “ closing” operation , (8) apply a boundary search algorithm that proceeds
along the width of the image looking for top-most pixel with a value >0. After setting the
initial boundary conditions, apply area threshold to get a DAPI mask for each DAPI
image (The area threshold is set as 5 mm2, which is based on the apoptotic body size),
apply the intensity threshold to get a ARS mask for each ARS image (the intensity
threshold is set as the highest intensity of decalcified control slide image). Then input the
cell layer thickness (here set as 5 µm based on the average nuclei length) to generate a
layer mask. Apply this layer mask to each segmented mask (DAPI, ARS) to calculate
nuclear morphometrics (length, width, area, aspect ratio,and orientation) and the total
positive staining area within the layer. Repeat applying the layer mask on the segmented
mask until the end of the image. Finally, all data are exported to excel spreadsheet with
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Figure 6-3 Images process. A: original image B: make a mask of image C: set the
boundary of the tissue, D: set the layer thickness (5 mm) and continue applying layer
mask on the image, E: finish process, F: export the excel sheet
nuclei number, aspect ratio, apoptotic body number, ARS area, layer area and cell density.
As for SPARC and BSP images, the similar process was applied except that the intensity
threshold set for these images was the highest intensity of the control image and 10%
value of the highest intensity of these images (Figure 6-3).
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6.2.6 Statistical analysis
Analysis of variance (ANOVA) techniques with mean comparison with turkey test
were used for statistical analysis (Sigma-Stat software v3.5). Significance was set as a P
value less than 0.05.
6.3 Results
6.3.1 Osteogenesis of bone marrow and periosteum derived cells
1. H&E staining of bone marrow and periosteum cultures on 2D plastic and 3D hydrogel
H&E staining was used to make gross visual observations regarding cells and
extracellular matrix accumulation for 2D plastic and 3D hydrogel

cell cultures.

Comparing the cultures of bone marrow and periosteum cells on both 2D plastic (top of
Figure 6-4 and Figure 6-5) and 3D hydrogel (bottom of 6-4 and 6-5), these two cells
showed considerable similarity to each other within the same culture modality (2D VS
3D). Comparing the same cell types across different culture modality, both cell types on
both 2D plastic and 3D hydrogels, had multiple cell layers (3~4); their nuclear shape was
elongated; their cell / matrix layer thickness was around 15~20 µm; and there appeared to
be some extracellular matrix substance surrounding the cells. Differences were noted
when comparing cultures on 2D plastic versus similar cultures on 3D collagenfibronectin hydrogels: 3D cultures exhibited a more intense staining, and had contained a
few migrated cells in the underlying gel (Asterisks in Figure 6-4, 6-5).
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Figure 6-4 Representative images of H&E staining of bone marrow cultures on
2D plastic VS 3D control. T: top of the culture, B: bottom of the culture, Asterisks :
point to migrating cells. For both cultures, the bottom refer to the plastic wall of the
plate. Bars indicate linear measures used to determine the thickness of major
cell/matrix layer.
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Figure 6-5 Representative images of H&E staining of periosteum cultures on 2D
plastic VS 3D control. T: top of the culture, B: bottom of the culture, Asterisks : point
to migrating cells. For both cultures, the bottom refer to the plastic wall of the plate.
Bars indicate linear measures used to determine the thickness of major cell/matrix
layer.
2. Quality of immuno-histochemical staining of BSP and SPARC and chemical staining
of minerals of calcium bone marrow and periosteum cells on 2D plastic and 3D hydrogels.
Representative images of DAPI, SPARC and ARS staining of bone marrow cells
and periosteum cells in differentiation medium are shown in Figure 6-6 through 6-9.
These two cell type showed roughly similar staining patterns on both 2D plastic and 3D
hydrogel. When comparing the cultures on 2D plastics versus 3D hydrogels, both cell
types had multiple cell layers, and had positive staining areas of SPARC and ARS. Some
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differences were noted regarding a little bit more positive SPARC and ARS stained areas
on 3D hydrogel than on 2D plastic.
Representative images of DAPI, BSP and ARS staining of bone marrow cells and
periosteum cells in differentiation medium are shown in Figure 6-10 through 6-13. Again
these two cells showed roughly similar staining patterns on both 2D plastics and 3D
hydrogels. When comparing the cultures on 2D plastics and 3D hydrogels, both cell types
had multiple cell layers and positive staining area for BSP and ARS. As observed for
SPARC staining there seemed to be a little more positive BSP and ARS stained area on
3D hydrogels than on 2D plastics.
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Figure 6-6 Representative images of SPARC and ARS staining of bone marrow
cells cultures on 2D plastic in differentiated medium. T: top of the culture, B:
bottom of the culture. Scale bar: 50 µm and 10 µm in low and high magnification
images respectively. Low magnification images are in the left column of each group
images. High magnification images are in the right column of each group images.
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Figure 6-7 Representative images of SPARC and ARS staining of bone marrow
cells cultures on 3D hydrogels in differentiation medium. T: top of the culture, B:
bottom of the culture. Scale bar: 50 µm and 10 µm in low and high magnification
images respectively. Low magnification images are in the left column of each group
images. High magnification images are in the right column of each group images.

104

Figure 6-8 Representative images of SPARC and ARS staining of periosteum
cells cultures on 2D plastic in differentiated medium. T: top of the culture, B:
bottom of the culture. Scale bar: 50 µm and 10 µm in low and high magnification
images respectively. Low magnification images are in the left column of each group
images. High magnification images are in the right column of each group images.
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Figure 6-9 Representative images of SPARC and ARS staining of periosteum
cells cultures on 3D hydrogel. T: top of the culture, B: bottom of the culture. Scale
bar: 50 µm and 10 µm in low and high magnification images respectively. Low
magnification images are in the left column of each group images. High magnification
images are in the right column of each group images.
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Figure 6-10 Representative images of BSP and ARS staining of bone marrow
cells cultures on 2D plastic in differentiated medium. T: top of the culture, B:
bottom of the culture. Scale bar: 50 µm and 10 µm in low and high magnification
images respectively. Low magnification images are in the left column of each group
images. High magnification images are in the right column of each group images.
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Figure 6-11 Representative images of BSP and ARS staining of bone marrow
cells cultures on 3D hydrogel in differentiation medium. T: top of the culture, B:
bottom of the culture. Scale bar: 50 µm and 10 µm in low and high magnification
images respectively. Low magnification images are in the left column of each group
images. High magnification images are in the right column of each group images.
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Figure 6-12 Representative images of BSP and ARS staining of periosteum cells
cultures on 2D plastic in differentiated medium. T: top of the culture, B: bottom
of the culture. Scale bar: 50 µm and 10 µm in low and high magnification images
respectively. Low magnification images are in the left column of each group images.
High magnification images are in the right column of each group images.
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Figure 6-13 Representative images of BSP and ARS staining of periosteum cells
cultures on 3D hydrogel in differentiation medium. T: top of the culture, B: bottom
of the culture. Scale bar: 50 µm and 10 µm in low and high magnification images
respectively. Low magnification images are in the left column of each group images.
High magnification images are in the right column of each group images.
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3. Quantity of cell density, extracellular matrix and calcium mineral of bone marrow and
periosteum cell cultures on 2D plastic and 3D hydrogels.
To quantify cell density, immuno-histochemical staining of SPARC or BSP, chemical
staining of calcium mineral and nuclei morphology of bone marrow and periosteum cell
cultures on 2D plastic and 3D hydrogels, the top 5 layers were selected as main area of
interest since the total cell layer thicknesses on both 2D plastic and 3D hydrogel were no
more than 25 µm thick (Figure 6-4, 6-5), which would calculate to 5 layers, each of 5 µm
thickness. Figure 6-14 and 6-16 show the quantitative results of cell density (Figure 6-14),
extracellular matrix (Figure 6-15) and calcium mineral (Figure 6-16) of bone marrow and
periosteum cell cultures. Here, the quantity is defined as the average positive stained area
(µm2) per layer per standard image (around 1800 µm2).
A. Cell density
For each cell type, there were a total of four different culture conditions: growth
medium on 2D plastic, differentiation medium on 2D plastic, growth medium on 3D
hydrogel and differentiation medium on 3D hydrogel. Comparing the quantity of cell
density of the combined eight groups (bone marrow and periosteum) with three way
ANOVA with a means comparison using a tukey test (factor one is cell type, factor two is
culture medium, factor three is culture modality (2D VS 3D)) (Figure 6-14), none of
these three factors (cell type, culture medium and culture modality) is a factor having
significant influence on the cell density. Specifically, there was no significant difference
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between the cell density of the bone marrow and periosteum cell cultures, no significant
difference between the cell density of the cultures with growth medium and
differentiation medium, and no significant difference between the cell density of the
cultures

on

2D

plastics

and

3D

hydrogel

(p

values

in

table

6-1).

Figure 6-14 The Quantity and distribution of cell density of cells cultures on 2D
plastic VS 3D hydrogel.
B. SPARC and BSP
The quantity of immuno-histochemical staining of SPARC in these eight groups was
compared with a three way ANOVA with means comparison using a tukey test (factor
one is cell type, factor two is culture medium, factor three is culture modality (2D VS
3D)) (Figure 6-15A, Figure 6-15B). Cell type was not a factor having a significant
influence on the amount of SPARC staining area. Thus, there was no significant
difference found between the SPARC staining areas of the bone marrow vs periosteum
cell cultures. Culture medium was found to be a factor having a significant influence on
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the amount SPARC staining area. Specifically the SPARC staining area in differentiation
medium was significantly higher than in growth medium. Culture modality was found to
be a factor having a significant influence on the amount of SPARC staining area.
Specifically, the SPARC staining area on 3D hydrogels was significantly higher than on
2D plastics (p value in table 6-1).

Figure 6-15 The Quantity BSP and SPARC staining area of cells cultures on 2D
plastic VS 3D hydrogel.
The quantity of immuno-histochemical staining of BSP in these eight groups was
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compared with a three way ANOVA with means comparison using a tukey test (factor
one is cell type, factor two is culture medium, factor three is modality (2D VS 3D))
(Figure 6-15C, Figure 6-15D). Cell type was not a factor having a significant influence
on the amount of BSP staining area. Thus there was no significant difference found
between the BSP staining areas of bone marrow vs periosteum cell cultures. Culture
medium was found to be a factor having a significant influence on the amount of BSP
staining area. Specifically, BSP staining area in differentiation medium was significantly
higher than in growth medium. Culture modality was found to be a factor having
significant influence on the BSP staining area. Specifically, the BSP staining area on 3D
hydrogels was significantly higher than on 2D plastics (p value in table 6-1).
C. Calcium mineral

Figure 6-16 The Quantity of calcium mineral staining area of cells cultures on 2D
plastic VS 3D hydrogel.
The quantity of calcium mineral staining of these eight groups was compared with a
three way ANOVA with means comparison using a tukey test (factor one is cell type,
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factor two is culture medium, factor three is culture modality (2D VS 3D)) (Figure 6-16).
Cell type was not a factor having significant influence on the mineral staining area. Thus,
there was no significant difference between the calcium mineral staining area of bone
marrow and periosteum cell cultures. Culture medium was found to be a factor having a
significant influence on the amount of calcium mineral staining area. Specifically,
calcium mineral staining area in differentiation medium was significantly higher than in
growth medium. Culture modality was found to be a factor having a significant influence
on the amount of calcium mineral staining area. Specifically, calcium mineral staining
area on 3D hydrogels was significantly higher than on 2D plastics (p value in table 6-1).
Factors

Cell density

SPARC

BSP

ARS

Cell type

0.02

0.94

0.29

0.19

Culture medium

0.53

0.008

0.001

0.009

0.0001

0.0002

0.0001

Culture modality 0.03

Table 6-1 p value of quantitative analysis
In all, my results of this part studies showed that for both bone marrow and
periosteum there were more SPARC, BSP and mineral staining in the culture on 3D
hydrogel than on 2D plastic, which proved my first hypothesis that more extracellular
matrix and calcium mineral were deposited in the cultures of both periosteum and bone
marrow cells on 3D collagen-fibronectin hydrogel comparing with the culture on 2D
conventional tissue plastic.
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4. Distribution of cell density, extracellular matrix and calcium mineral of bone marrow
and

periosteum

cell

cultures

on

2D

plastic

and

3D

hydrogels.

Figure 6-17 The distribution of cell density of cultures on 2D plastic VS 3D
hydrogel.
The original distribution of cell density, extracellular matrix and calcium mineral of
the cell cultures on 2D plastic vs 3D hydrogel are shown in Figure 6-17 to Figure 6-19.
The extracellular matrix and calcium mineral in the first layer can only be deposited by
the cells in the first and/or second layers, while in the remaining cell layers they can be
deposited by all the layers surrounding them, therefore the first layer is distinguished
from all the remaining layers. Thus, percentage of the first layer staining area to the total
staining area can be used as a parameter used to compare the distribution pattern of
extracellular matrix and calcium mineral on the cultures.
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Figure 6-18 The distribution BSP and SPARC staining areas of cells cultures on
2D plastic VS 3D hydrogel.

Figure 6-19 The distribution of calcium mineral staining area of cells cultures on
2D plastic VS 3D hydrogel.
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A. Cell density

Figure 6-20 The percentage of cell density in first layer VS rest layers.
Comparing the percentage of cell density in first layer of the combined eight groups
(bone marrow and periosteum) with three way ANOVA with a means comparison using a
tukey test (factor one is cell type, factor two is culture medium, factor three is culture
modality (2D VS 3D)) (Figure 6-20), cell types and culture medium were not factors
having significant influence on the percentage of cell density in first layer. Specifically,
there was no significant difference between the percentage of first layer of the bone
marrow and periosteum cell cultures, no significant difference between the percentage of
cell density in first layer with growth medium and differentiation medium. Culture
modality was found to be a factor having a significant influence on the percentage of cell
density. Specifically, the percentage of cell density in first layer on 3D hydrogels was
significantly higher than that on 2D plastics (p value in table 6-2). This suggested that the
cells density distribution on 3D hydrogel was different from that on 2D plastic.
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B. SPARC and BSP
The percentage of immuno-histochemical staining of SPARC in the first layer of
these eight group cultures was compared with a three way ANOVA with means
comparison using a tukey test (factor one is cell type, factor two is culture medium, factor
three is culture modality (2D VS 3D)) (Figure 6-21). None of these three factors (cell
type, culture medium and culture modality) was a factor having significant influence on
the percentage of immuno-histochemical staining of SPARC in the first layer.
Specifically, there was no significant difference between the percentage of immunohistochemical staining of SPARC in the first layer of the bone marrow and periosteum
cell cultures, no significant difference between the percentage of immuno-histochemical
staining of SPARC in the first layer of the cultures with growth medium and
differentiation medium, and no significant difference between the percentage of immunohistochemical staining of SPARC in the first layer of the cultures on 2D plastics and 3D
hydrogel (p value in table 6-2). In all no difference of SPARC distribution was found
between these 8 groups.
The percentage of immuno-histochemical staining of BSP in the first layer of these
eight group cultures was compared with a three way ANOVA with means comparison
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Figure 6-21 The percentage of immuno-histochemical staining SPARC and
BSP in first layer VS rest layers.
using a tukey test (factor one is cell type, factor two is culture medium, factor three is
culture modality (2D VS 3D)) (Figure 6-21). None of these three factors (cell type,
culture medium and culture modality) was a factor having significant influence on the
percentage of immuno-histochemical staining of BSP in the first layer. Specifically, there
was no significant difference between the percentage of immuno-histochemical staining

120

of BSP in the first layer of the bone marrow and periosteum cell cultures, no significant
difference between the percentage of immuno-histochemical staining of BSP in the first
layer of the cultures with growth medium and differentiation medium, and no significant
difference between the percentage of immuno-histochemical staining of BSP in the first
layer of the cultures on 2D plastics and 3D hydrogel (p value in table 6-2). In all no
difference of BSP distribution was found between these 8 groups.
C. Calcium mineral

Figure 6-22 The percentage of calcium mineral in first layer VS rest layers
The percentage of chemical staining of calcium mineral in the first layer of these
eight group cultures was compared with a three way ANOVA with means comparison
using a tukey test (factor one is cell type, factor two is culture medium, factor three is
culture modality (2D VS 3D)) (Figure 6-22). None of these three factors (cell type,
culture medium and culture modality) was a factor having significant influence on the
percentage of chemical staining of calcium mineral in the first layer. Specifically, there
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was no significant difference between the percentage of chemical staining of calcium
mineral in the first layer of the bone marrow and periosteum cell cultures, no significant
difference between the percentage of chemical staining of calcium mineral in the first
layer of the cultures with growth medium and differentiation medium, and no significant
difference between the percentage of chemical staining of calcium mineral in the first
layer of the cultures on 2D plastics and 3D hydrogel (p value in table 6-2). In all no
difference of calcium distribution was found between these 8 groups.
Factors

Cell density

SPARC

BSP

ARS

Cell type

0.86

0.36

0.10

0.06

Culture medium

0.35

0.76

0.06

0.09

0.06

0.85

0.62

Culture modality 0.0001

Table 6-2 p value of distribution analysis
In all, my results of this part studies showed that for both bone marrow and
periosteum there were no difference between the distribution of SPARC, BSP and
mineral staining in the culture on 3D hydrogel with that on 2D plastic; while there was
significant difference between the distribution of cell density on 3D hydrogel with that on
2D plastic. This proved partly my second hypothesis that cell density in bone marrow and
periosteum 3D collagen fibronectin hydrogel cell cultures will exhibit a basal lateral
deposition pattern while not on 2D conventional tissue plastic, while partly rejected my
second hypothesis that extracellular matrix protein and mineral deposition in bone
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marrow and periosteum 3D collagen fibronectin hydrogel cell cultures will exhibit a basal
lateral deposition pattern while not on 2D conventional tissue plastic.
6.3.2 Nuclear morphologies of bone marrow and periosteum cells on 2D plastic and
3D hydrogel cultures
As shown in Figure 6-1, in vivo periosteum tissue exhibits cells at different
osteogenic stage having different morphologies. The quantity of nuclei aspect ratio of
these eight groups was compared with three way ANOVA with means comparison using
a tukey test (factor one is cell type, factor two is culture medium, factor three is culture

Figure 6-23 The quantity of nuclear aspect ratio of cells cultures on 2D plastic VS
3D hydrogel.
modality (2D VS 3D)) (Figure 6-23), none of these three factors (cell type, culture
medium and culture material) was a factor having significant influence on the nuclear
aspect ratio. Specifically, there was no significant difference found between the nuclear
aspect ratio of the bone marrow and periosteum cell cultures (p = 0.35), no significant
difference between the nuclear aspect ratio of the cultures with growth medium and
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differentiation medium (p = 0.03), and no significant difference between the nuclei aspect
ratio of the cultures on 2D plastics and 3D hydrogel (p = 0.11).
The distribution of cell nuclei distribution was shown in Figure 6-24. One way
ANOVA was used to compare the aspect ratio of nuclei among all the five layers in each
culture to test the hypothesis that cells at different osteogenesis stage have different
nuclear morphology.

For each culture, the result showed there was no significant

difference of the aspect ratio of nuclei among the five layers, which suggest there was no
different of nuclei morphology among the five layers in each culture. Therefore, it
rejected my third hypothesis that cells at different osteogenesis stage have different
nuclear morphology.

Figure 6-24 The distribution of nuclear aspect ratio of cells cultures on 2D plastic
VS 3D hydrogel.
6.3.3 Osteogenesis of bone marrow and periosteum cells
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All the results from above suggested that cell type was not a factor that has significant
influence on the amount and distribution of cell density, SPARC, BSP deposit, calcium
mineral deposit and nuclear morphology of the cell cultures. This proved my fourth
hypothesis that osteo-progenitors derived from bone marrow and periosteum cells exhibit
equivalent osteogenic capacity.
6.4 Discussion
Culture condition is an important component to be considered in my system. In vivo,
bone formation cells lay on the osteoid layer to form bone (Figure 6-1), which is secreted
by osteoblasts and becomes mineralization. Therefore, we propose that the chemicals in
this layer and its structure are important for bone formation. To mimic this layer, an
artificial osteoid layer was made from type I collagen and fibronectin. And the
osteogenesis of primary bone cells cultured on this layer was compared with that on 2D
plastic (Chapter VI). My results showed that there was significant increase of
extracellular matrix (SPARC, BSP) and calcium mineral deposition in the culture on 3D
collagen- fibronectin hydrogel than that on 2D plastic, which suggested that this artifical
osteoid layer promoted osteogenesis of primary bone cells. This matches with previous
studies showing that collagen [6, 22, 30, 33, 49, 65] and fibronectin [60] promoted
osteogenesis of bone cells. Barralet et al. cultured bone marrow cells on type I collagen
gels for 21-28 days and showed new osteoid-like tissue formation by these cells [6].
Wiesmann et al. cultured periosteal derived osteoblasts on Petri dishes as well as within
3D collagen constructs. They showed that these cells can form ‘bone like’ mineral
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deposits in both 2- and 3-D environments and formed an extracellular matrix containing
osteocalcin, SPARC (osteonectin), and newly synthesized collagen type I in both
environments [89]
Moreover, the polarity of cells, extracellular matric and calcium mineral deposition
on this 3D collagen fibronectin hydrogel was analyzed. My results showed the polarity of
cell density distribution on 3D collagen fibronectin hydrogel and no polarity on the
distribution of extracellular matrix and mineral deposition, which may because that
overall very small amount extracellular matrix and calcium mineral deposited on 3D
collagen fibronectin cultures, which suggest that my end time point is the initial
differentiation time point (bone cells starts to deposit extracellular matrix and mineral);
and no polarity would be generated at this time point of culture.
Cell source is one key component in bone tissue engineering [39, 66], until now,
bone cell sources used in bone tissue engineering have included mesenchymal stem cells
derived from bone marrow, perioteum and umbilical et al [5, 6, 13, 29, 30, 33, 39, 42, 51,
76-79, 89], and mature osteoblasts, such as trabecular bone obtained during iliac crest
biopsies [60]. Osteo-progenitors derived from bone marrow and periostum are two
popular cell types are used in bone tissue engineering. My results that osteo-progenitors
derived from bone marrow and periosteum cells exhibit equivalent osteogenesis, which
suggested that both cell types are appropriate for the use in this model system.
There were some limitations that should be addressed in future. Studies includes: (1)
to investigate the polarity of cell cultures on 3D collagen fibronectin hydrogel, cultures
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with extended culture time (6 week) will be needed. (2) Multiple experimental time
points will be needed to investigate the cell osteogenesis status. (3)The amount of
extracellular matrix in the culture medium needs to be measured to have a better
comparison between the cultures on 3D collagen fibronectin hydrogel and 2D plastic. (4)
The markers of cell osteogensis stage (e.g. alkaline phosphatase (osteoblast cells), E11
(pre-osteocyte) [9, 66]) will be stained on the serial slides of the culture to determine
whether cells in the culture are at different osteogenesis stage. (5) F-actin [54] needs to be
stained to determine the morphology of cells which enable us to investigate the
relationship between cell morphology and cell osteogenesis status.
In all, the results in this Chapter indicate that bone marrow and periosteum cells
exhibit similar osteogenesis on both 2D plastic and 3D hydrolgel, and that the 3D
collagen-fibronectin hydrogel promoted osteoblasts osteogenesis. Applying this
knowledge to our prospective bone tissue engineerin3D bioreactor system, we propose to
use 3D collagen-fibronectin hydrogel as interface between cells and scaffolds to promote
osteoblasts osteogenesis, and to use either bone marrow or periosteum cells as the cell
source.
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CHAPTER VII
DISCUSSIONS AND CONCLUSIONS

Large-sized bone defects and recalcitrant fractures require surgical intervention with
grafting materials to provide the best potential for healing [1, 4]. Around 10 billion
dollars in United States and 24 billion dollars worldwide are expended annually to treat
large-sized cortical bone damage with graft materials, such as autografts, allografts and
synthetic grafts [4, 39, 69]. However, even these graft materials have limitations and may
seem unsuitable for some clinical needs. Cortical bone tissue engineering provides a
promising approach to generate new graft materials that may satisfy these clinical needs
[39, 66]. Yet, cortical bone tissue has not been produced in vitro to date using
engineering approaches. In order to generate ample amounts of cortical bone with a tissue
engineering approach, three key aspects need to be considered: 1) an optimal osteogenic
cell source needs to be identified, 2) biocompatible scaffold materials with similar
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mechanical and permeability properties as cortical bone needs to be identified thereby
providing immediate functional bone capacity, and 3) optimal culture conditions ( such as
collagen scaffold)need to be identified that will promote osteogenesis of bone cells [66].
In this dissertation work I set out to develop a cortical bone tissue engineering
system that would mimic the three cortical bone layers to promote functional cortical
bone formation in vitro. Specifically, the tissue engineering bone model system proposed
(Figure 2-2) would be composed of a biocompatible scaffold with similar mechanical
strength and permeability as cortical bone; an artificial osteoid layer made of type I
collagen and fibronectin in hydrogel format to mimic the osteoid layer and osteogenic
bone cells mimic the bone cell layer. We expect a functional bone tissue can be generated
from this system in the future. To set up this bone model system these three components
need to be tested and selected.
7.1 Characterization of Scaffold material
Different biomaterials have been used in bone tissue engineering. They include
metals (such as cobalt-chromium alloys, stainless steel and titanium), synthetic polymers
(such as PMMA), ceramics, natural collagens and their bio-composites [39, 66, 95].
Among all these materials, some match the mechanical property (such as ceramics and
metals), some match the permeability property (such as porous metals, porous polymer
and porous ceramics), and some exhibit appropriate biocompatibility [66]. PMMA and
316L stainless steel were tested as candidate scaffolds since they are cost effective, easy
to be manufactured into any shape and size needed, and more important have similar pore
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size as cortical bone are reported to be biocompatible (Chapter III). To determine whether
these two material scaffolds are appropriate for the use in our system, we measured their
mechanical and hydraulic permeability properties, as well as their short term and long
term- biocompatibility. My results showed that PMMA exhibited roughly similar
hydraulic permeability as cortical bone and an appropriate biocompatibility for short term
bone cell culture; and that 316L stainless steel exhibited roughly similar ultimate tensile
strength and hydraulic permeability as cortical bone and an appropriate biocompatibility
for both short term and long term bone cell culture. These biocompatibility results match
with previous studies on the biocompatibility of stainless steel and PMMA; such as:
Puleo et al. [61] showed that stainless steel exhibits good short term biocompatibility; and
Ramachandran et al [71]. showed that osteoblasts exhibited phenotypic stability when
cultured on PMMA suggesting that PMMA exhibits adequate biocompatibility. In the
other hand, these results disagree with some other studies; such as Jocobs et al.[36] stated
that 316 L stainless steel containing chromium (16-18%) and nickel (10-14%) was a
probable source of long-term complications, and their findings suggested caution for its
use as an implant; Chiu et al. [13] showed that PMMA inhibits the proliferation and
osteogenic differentiation of bone marrow cells suggesting that PMMA may not always
exhibit high levels of biocompatibility. The difference of the biocompatibility of stainless
steel between mine and Jocobs’ may come from the difference in the test methods: mine
are in vitro experiment results while theirs are in vivo experiment results. The difference
of biocompatibility of PMMA between mine and Chiu’s may come from the difference of
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the outcomes: mine are the proliferation rate of the cells while theirs are the osteogenesis
properties. Therefore, based on my results, these two scaffold materials were appropriate
for our system. Our first choice would be 316L stainless steel, and the second choice
would be PMMA.
7.2 Hydraulic permeability of cortical bone
One criterion for the selection the scaffold material used in my bone model system is
the hydraulic permeability of cortical bone. Because in vivo fluid flow is critically
important for the nutrient and waste product transport, which is important to maintain
osteocyte viability and regulate the physiological processes of bone remodeling and
homoestasis [7, 98 ]. Until now, few studies have experimentally measured the hydraulic
permeability of cortical bone in part because of the engineering challenges in measuring
extreamly low permeabilities. These devices require high pressure tolerances in both the
bone tissue holding chamber and other upstream components of the permeability device
in order to accurately measure the permeability of cortical bone. Therefore, the hydraulic
permeability of cortical bone and the contribution of bone components to its hydraulic
permeability were studied in Chapter IV. My permeability results showed that the
permeability of fresh cortical bone from endosteum side was below the detection limit of
my device (4 x 10-17); after removing the lipids from the porous compartment of cortical
bone, its permeability was increased around 3 fold; after removing the collagen in the
porous compartment of cortical bone, its permeability was increased another 5 fold; after
removing the crystal minerals, its permeability was increased another 5 fold. These
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results match with Li’s study [46]. They reported that the radial permeability of adult
canine tibial cortex was 5 x 10-17 m2 and that the radial permeability of puppy bone was 6fold higher than that of adult canines. In addition, they suggested that the periosteal
portion of cortical bone was relatively impermeable as compared to the endosteal portion
of cortical bone. My lipids results showed that the composition of the extracted lipids
from porous compartment in cortical bone consisted of ~60% triacylglycerols, ~4% fatty
acids, ~1% phospholipids and 11% cholesterol; which matched with previous reports
measuring the lipid contents of human [19] or ox [45] cortical bone, respectively, and
finding high levels of triacylglycerols and low levels of phospholipids. In addition my
hydroxyproline results showed that the relative proportion of the porous to non-porous
collagen content calculates to be 4.9%, which approximates the relative volume ratio of
these two compartments of cortical bone; which match with previous report of porosity of
cortical bone (2~10%) [9, 14]. These results suggested that we might be able to decrease
the permeability of scaffold materials by coating them with lipids and / or collagen to
adjust their overall permeability similar to that of cortical bone.
7.3 Glucose diffusion
Glucose supply always needs to be considered in bone tissue engineering since it is
essential to maintain cell viability [66]. Under static culture conditions, glucose transport
is only mediated by diffusion. To determine when glucose becomes limited in our system,
the glucose concentration profile needed be calculated based on the diffusion coefficient
of glucose in cortical bone. Therefore the diffusion coefficient of glucose in cortical bone
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was experimental measured and mathematical modeling was established to generate the
glucose concentration profile in Chapter IV. I can not measure the glucose diffusion
coefficient with current diffusion chamber. With the measurement of the bone porosity, I
can calculate the diffusion coefficient of cortical bone (3.15 x 10-9 cm2/s) based on the
correlation of porosity, tortuosity and permeability established by previous study [2, 73].
In addition, a mathematical model was established based on the transport principles to
predict the glucose concentration in scaffold (here is cortical bone) and cell layers in my
model system. Base on this model, the largest thickness bone tissue can be generated
from this system on 300µm cortical bone was 50 µm. Thus, to generate more bone tissue,
the glucose transport needs to be increased in this system, which can be done by applying
mechanical load in this system.
7.4 Cell source and culture conditions
Cell source is one key component in bone tissue engineering, until now, bone cell
sources used in bone tissue engineering have included mesenchymal stem cells derived
from bone marrow, perioteum and umbilical et al, and mature osteoblasts, such as
trabecular bone obtained during iliac crest biopsies[5, 6, 13, 29, 30, 33, 39, 42, 50, 51,
76-79, 89]. Osteo-progenitors derived from bone marrow and periostum are two popular
cell types are used in bone tissue engineering. Previous Studies showed that both cell
types have osteogenesis properties. Barralet et al. [6] cultured bone marrow cells on type
I collagen gels for 21-28 days and showed new osteoid-like tissue formation by these
cells. Sikavitsas et al. [78] cultured bone marrow cells in a flow perfusion bioreactor and
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showed that such a fluid-flow bioreactor culture system minimized diffusion constraints
and provided mechanical stimulation to the bone marrow cells, leading to the
accumulation of a cancellous bone-like mineralized tissue. Wiesmann et al [89] cultured
periosteal derived osteoblasts on Petri dishes as well as within 3D collagen constructs.
They showed that these cells can form ‘bone like’ mineral deposits in both 2- and 3-D
environments and formed an extracellular matrix containing osteocalcin, SPARC
(osteonectin), and newly synthesized collagen type I in both environments. Koshihara et
al [48] showed that periosteum cells are osteoblastic cells and could differentiat into
osteocytes and deposited calcified mineral in response to 1, 25 dihydroxyvitamin D3 . To
select the cell source used in my model system, osteogenesis of these two cell types were
compared side by side on both 2D conventional tissue plastic and 3D collagen fibronetin
hydrogel. Our results showed that there was no significant difference between the
osteogenesis of these two cell types. Therefore either of these two cells can be used in our
system.
Culture condition is another important component to be considered in my system. In
vivo, bone formation cells lay on the osteoid layer to form bone (Figure 6-1), which is
secreted by osteoblasts and becomes mineralization. Therefore, we propose that the
chemicals in this layer and its structure are important for bone formation. To mimic this
layer, an artificial osteoid layer was made from type I collagen and fibronectin. And the
osteogenesis of primary bone cells cultured on this layer was compared with that on 2D
plastic (Chapter VI). My results showed that there was significant increase of
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extracellular matrix (SPARC, BSP) and calcium mineral deposition in the culture on 3D
collagen- fibronectin hydrogel than that on 2D plastic, which suggested that this artifical
osteoid layer promoted osteogenesis of primary bone cells. This matches with previous
studies showing that collagen [6, 22, 30, 33, 49, 65] and fibronectin [60] promoted
osteogenesis of bone cells. Moreover, the polarity of cells, extracellular matric and
calcium mineral deposition on this 3D collagen fibronectin hydrogel was analyzed. My
results showed the polarity of cell density distribution on 3D collagen fibronectin
hydrogel and no polarity on the distribution of extracellular matrix and mineral
deposition, which may because that overall very small amount extracellular matrix and
calcium mineral deposited on 3D collagen fibronectin cultures, which suggest that my
end time point is the initial differentiation time point (bone cells starts to deposit
extracellular matrix and mineral); and no polarity would be generated at this time point of
culture.
7.5 Future direction
1. Scaffold material
There were some limitations in characterizing the scaffold material that should be
addressed in future, which include: (1) the long term biocompatibility of PMMA will be
tested; (2) osteogenesis potential of bone cells cultured on these material will be
measured basing on the deposition amount of extracellular matrix (alkaline phosphatase
(expressed at early stage of differentiation), BSP (expressed at later stage of
differentiation) and calcium mineral on these cultures with simple biochemistry methods;
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specifically the amount of activity of alkaline phosphatase can be measured with alkaline
phosphatase assay kit (BioAssay System), amount of the BSP can be measured with west
blotting method and the mount of calcium mineral can be measured with a colorimetric
method; 3) Sample size will be increased to be able to exclude random variability.
2. Hydraulic permeability of cortical bone
There were some limitations in measuring the hydraulic permeability of cortical bone
that should be addressed in future, which include: (1) the hydraulic permeability of fresh
cortical bone will be measured. To do this there are two methods can be used: (a) with
current device, the bone wafers can be cut into several pieces of thinner wafers with same
thickness and the hydraulic permeability of these wafers will be measured at same
conditions; then the hydraulic permeability of bone wafers will be average of all these
measurements; (b) a new device with lower detection limit needs to be made. Right now
the detect limit of the present device results from the pressure limit of the holder made of
PVC. Therefore, the bone holder made from stainless steel with same design as proposed
in this chapter will increase the pressure limit of the bone holder thereby lower the
detection limit. Compare to method (a) the advantage of this method is that the hydraulic
permeability can be measured directly and the disadvantage is that some cost will be
applied on the new device. (2) Hydraulic permeability of the cortical bone from
periosteum side and the contribution of bone components to its permeability need to be
studied to understand the mechanism of the nutrient and waste transport underneath
periosteum layer, which is critical important for bone formation in vivo. To do this, a new
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device with much lower detect limit needed. (3) Changes in ultrastructure of the
remaining pericellular matrix after removing lipids and / or collagen may have effect on
the changes on the permeability. To determine whether there is the change of
ultrastructure, transmission electron microscopy (TEM) images of the wafers after
collagenase and or acetone methonal treatment need to be compared with that of the
wafers before treatments.
3. Glucose diffusion
There were some limitations in measuring the diffusion coefficient of glucose in
cortical bone that should be addressed in future, which include: (1) the glucose diffusion
coefficient in cortical bone will be measured with a more sensitive detection method
needs to apply this system, such as using radiolabel chemicals. (2) Diffusion coefficient
of oxygen will be studied to generate the oxygen concentration profile with this model
system. (2) Diffusion coefficient of hydrophobic molecular (such as prostaglandin [64])
in cortical bone will be studied to better understand the nutrient transport inside the bone.
(3) The diffusion coefficient of glucose in cortical bone under mechanical load will be
studied to better understand the nutrient transport inside the bone. (4) Convection factors
will be included in the model system to predict the glucose concentration profile in the
system with mechanical load.
4. Cell source and culture condition
There were some limitations in selecting the cell source and culture conditions that
should be addressed in future, which include: (1) Cultures with extended culture time (6
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week) will be done to investigate the polarity of cell cultures on 3D collagen fibronectin
hydrogel. (2) Multiple experimental time points will be done to investigate the cell
osteogenesis status. (3)The amount of extracellular matrix in the culture medium will be
measured to have a better comparison between the cultures on 3D collagen fibronectin
hydrogel and 2D plastic. (4) F-actin will be stained to determine the morphology of cells
which enable us to investigate the relationship between cell morphology and cell
osteogenesis status.
7.6 Significance of this work
Clinically there is a need for bone graft alternatives. However there are no functional
bone grafts that have been generated to meet this demand. My approach and system
design provide a means for studies to be conducted towards the development of
functional bone tissue in vitro. My ultimate goal is to generate a functional bone tissue on
a biocompatible scaffold, which will be peeled off from the scaffold and used as bone
scaffold material to treat large size bone defect. The data in this work provide the basis
for future studies that may incorporate growth factors, mechanical stimuli and co-culture
of different cells types in this bone model system to promote sustained bone formation in
vitro.
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